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ABSTRACT OF THE DISSERTATION
THE RELATIONSHIP AMONG SERUM LEVELS OF MANGANESE
SUPEROXIDE DISMUTASE AND MITOCHONDRIAL DNA 8-HYDROXY-2’DEOXYGUANOSINE, AND DIETARY ANTIOXIDANTS INTAKE IN
TYPE 2 DIABETES
By
Michael Andrew McLean
Florida International University, 2014
Professor Fatma G. Huffman, Major Professor
Oxidative stress plays a key role in the development of Type 2 Diabetes (T2D).
This cross-sectional study examined the relationship among serum levels of manganese
superoxide dismutase (MnSOD), 8-hydroxy-2’-deoxyguanosine (8OHdG), dietary
antioxidant intakes and glycemic control in African Americans (n=209) and Haitian
Americans (n=234) with and without T2D.
African Americans had higher BMI (32.8 vs. 29.3 kg/m2), higher energy intake
(2148 vs. 1770 kcal), and were more educated as compared to Haitian Americans; all
variables were significant at p < .001. Serum levels of 8OHdG and MnSOD for African
Americans (1691.0 ± 225.1 pg/ml, 2538.0 ± 1091.8 pg/ml; respectively) were
significantly higher than for Haitian Americans (1626.2 ± 222.9, 2015.8 ± 656.3 pg/ml;
respectively). 8OHdG was negatively correlated with MnSOD (r = -.167, p < .001) in
T2D. Having T2D was negatively correlated with MnSOD (r = -.337; p < .01) and
positively correlated with 8OHdG (r = .500; p < .01). African Americans and Haitian
Americans with T2D had fasting plasma glucose (FPG) levels of 143.0 ± 61.0 mg/dl and
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157.6 ± 65.5 mg/dl, and A1C of 7.5 ± 1.8 % and 8.4 ± 2.4 %, respectively. African
Americans and Haitian Americans without T2D had FPG levels of 95.8 ± 13.2 mg/dl and
98.7 ± 16.9 mg/dl, and A1C of 5.9 ± 0.4% and 6.0 ± 0.5%, respectively. Dietary intakes
of vitamin C and vitamin D were negatively correlated with FPG (r = -.21; r = -.19, p <
.05) respectively. Carotenoids negatively correlated with A1C (r = -.19, p < .05). Lower
levels of MnSOD were associated with lower levels of zinc, r = .10, p < .05, and higher
levels of carotenoids r = -.10, p < .05. Higher levels of 8OHdG were associated with
lower levels of Vitamin D, r = -.14, p < .01, and carotenoids, r = -.09, p < .05.
The results demonstrate greater oxidative mtDNA damage in persons with T2D
compared to those without T2D and in African Americans compared with Haitian
Americans. The inverse relationship between dietary intake of antioxidants and oxidative
stress implies a potential to reduce oxidative stress with diet.
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CHAPTER I
INTRODUCTION
The United States Census Bureau (2009) reported that the Haitian American
population in the United States (U.S.) is approximately 830,000, two thirds of whom live
in Florida and New York. An intensive search of the literature resulted in very little
health care information about the population of Haitian descent and it is unclear how their
glycemic control, dietary intake of antioxidants, and oxidative stress biomarkers compare
with African Americans. African Americans have higher mean A1C (Kirk et al., 2006;
Manickham et al., 2013), lower dietary antioxidants plasma biomarkers (Arab et al.,
2011), and increased oxidative stress biomarkers and inflammation (Feairheller et al.,
2011; Cook et al., 2013) than whites. There are no studies on glycemic control, oxidative
stress biomarkers, or dietary antioxidant in Haitians. In addition, there are no studies that
compared African Americans with Haitian Americans with and without Type 2 Diabetes
(T2D) as investigated by this study.
Diabetes is of epidemic proportions, and T2D accounts for 90% - 95% of all
diabetes cases (Centers for Disease Control [CDC], 2011; O’Brien, Patrick, & Caro,
2000). According to the American Diabetes Association (ADA), there are 23.6 million
children and adults in the United States who are afflicted with diabetes, with
approximately 50% of whom are not aware that they have the disease. It is estimated that
5-10% of these patients have Type 1 (T1D), or insulin-dependent diabetes, and that the
remaining have T2D, or non-insulin dependent diabetes mellitus (NIDDM; ADA, 2013;
Demmer et al., 2013). T2D is the focus of the current research.
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The prevalence of diabetes in the United States is 8.3%, of which 12.6% of those
diagnosed with T2D are of African descent (ADA, 2013; Demmer et al., 2013). In 2007,
Rosen et al. investigated the prevalence of T2D in the Haitians. The investigators used
fasting glucose to determine the prevalence of T2D and found that the prevalence of T2D
was 33% (Rosen et al., 2007) in Haitians in the Miami-Haitian community. A report
prepared by The Health Council of South Florida for the Miami-Dade County Health
Department (2008) documented that death rates for Blacks were twice that of Whites and
Hispanics with T2D. It is clear that health disparity exist between African Americans
and Whites. There are gaps in scientific literature regarding health biomarkers in
Haitians and it is imperative to investigate the differences observed in the prevalence of
T2D in African Americans and Haitians.
Diabetes is clinically diagnosed by the use of a fasting plasma glucose (FPG) test
or oral glucose tolerance test (OGTT), and a diagnosis of diabetes is made when the
fasting plasma level of glucose is greater than or equal to 126 mg/dl (ADA, 2013). The
symptoms that are associated with diabetes are frequent urination, excessive thirst,
extreme hunger, unusual weight loss, increased fatigue, irritability, and blurry vision.
Diabetes risks may be categorized as either modifiable or non-modifiable. The
modifiable risk factors associated with diabetes are high blood glucose, obesity,
hypertension, abnormal lipid metabolism, smoking, physical inactivity, and inflammation
(ADA, 2013). The non-modifiable risk factors are age, ethnicity, gender, and family
history (Vanuzzo, Pilotto, Mirolo, & Pirelli, 2008; Giovannucci et al., 2010).
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Oxidative stress plays an important role in the progression of complications
associated with diabetes and the severity of the complications may be reduced with
dietary antioxidant supplements (Gopaul et al., 2001; Kiss & Szabo, 2005; Rains & Jain,
2011; West, 2000; Daien et al., 2013). Montonen, Järvinen, Knekt, and Reunanen (2004)
studied dietary antioxidant intakes and the development of T2D and found a negative
relationship between T2D symptoms and dietary intake of antioxidants in the form of
food or supplements.
High levels of glucose contribute to an increase in reactive oxygen species (ROS)
that up-regulate 8-oxoguanosine DNA glycosylase (OGG1) and decrease manganese
superoxide dismutase (MnSOD), both of which are indicators of enzymatic antioxidants
(Bolajoko et al., 2008; Ruchko et al., 2011). This effectively induces mtDNA damage,
whereby there is an increase in the byproduct mtDNA 8-hydroxy-2’-deoxyguanosine
(8OHdG; Bolajoko et al., 2008). 8OHdG is a byproduct of the DNA repair mechanism,
which has been used worldwide as a non-invasive method of identifying oxidative DNA
damage that can occur both in vivo and in cell cultures (Harri et al., 2007; Patel, Bevan,
Mistry, & Lunec, 2007; De Iuliis et al., 2009). The mitochondrion also produces
superoxide via reverse electron transport, and the body will normally up-regulate the
antioxidant enzyme MnSOD to neutralize its damaging effects (Ceriello, 2003; Abraham
et al., 2013).
Other studies have shown that riboflavin (Cobianchi et al., 2008; Schramm et al.,
2013), n-acetylcysteine (Deneke, 2000), and vitamin E (Clarke, Burnett, & Croft, 2008;
Niki, 2013) may all down-regulate the production of reactive oxygen species and assist
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the body’s antioxidant defense system. As such, the therapeutic use of antioxidant
nutrients as food or supplements can prevent oxidative damage (Jat et al., 2013; Landete,
2013).
The mechanism of DNA damage appears to be directly associated with oxidative
stress and impairment of mitochondrial oxidative phosphorylation (Lee & Pervaiz, 2011;
Suzuki et al., 1999). This impairment and defect results in the generation of the
byproduct 8OHdG, which has been documented as a sensitive biomarker of oxidative
stress, associated with a biochemical damaging effect on mitochondrial DNA (Ishikawa,
Fujioka, Ishimura, Takenaka, & Fujisawa, 2007; Johnston et al., 2010). 8OHdG is the
most frequently studied and validated biomarker of oxidative stress damage of the
mitochondrial DNA (Cooke, Henderson, & Evans, 2009). 8OHdG has been shown to be
stable in blood circulation and is measureable by the Enzyme-Linked Immunosorbent
Assay (ELISA) methodology using serum (Breton, Sichel, Bianchini, & Prevost, 2003).
There is a strong relationship between serum 8OHdG and creatine, but there is no
relationship between serum levels of 8OHdG and urinary 8OHdG (Soini et al., 2011). It
is believed that 8OHdG excretion from the urine may be dependent on kidney function,
which would justify not using urinary 8OHdG analysis in the T2D population (Soini et
al., 2011).
Statement of the Problem and Justification of the Study
The prevalence of T2D in the general population is well documented, and
research shows a disproportionate prevalence in ethnic/minority groups (Kim & Caprio,
2011; Richard, Alexandre, Lara, & Akamigbo, 2011), who experience poor outcomes and
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increased rates of complications associated with T2D (Richard et al., 2011). There are no
studies, however, that looked at 8OHdG and MnSOD in African Americans and Haitian
Americans, two ethnically different groups that are normally grouped together. This
study provides data on the serum levels of 8OHdG, MnSOD, dietary antioxidant and
A1C in African Americans and Haitian Americans. The relationship between these
variables was also determined. The literature provides strong evidence of a protective
effect of MnSOD on cell apoptosis. Improvement in the deficient level of MnSOD may
provide an ameliorative effect on diabetes complications resulting from programmed cell
death (Kannan & Jain, 2000; Kowluru, Atasi, & Ho, 2006; Kaminski et al., 2012).
This study also investigated the levels of dietary intake of antioxidants in African
Americans and Haitian Americans, in addition to establishing a relationship between
dietary intake of antioxidant nutrients and the serum levels of MnSOD. Finally, this
study provides valuable information for potential intervention studies on therapeutic
approaches (Li & Zhou, 2011) to reduce progressive disorders associated with T2D.
Purpose of the Study
The purpose of this study was to determine the relationship between oxidative
stress biomarkers that included mitochondrial DNA damage and serum MnSOD and to
explore the relationship between these parameters of oxidative stress and dietary
antioxidant intake. Another purpose was to identify whether there are ethnic differences
in these biomarkers in participants with and without T2D. The study provides
information on dietary intakes of antioxidant nutrients and their relationship with
circulating oxidative stress biomarkers in persons with and without T2D.
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Hypotheses and Specific Aims
Aim 1: To determine differences in the serum levels of MnSOD and 8OHdG by
diabetes status and ethnicity.
Hypothesis 1a: Serum levels of MnSOD will be lower in participants with T2D as
compared to those without T2D, independent of ethnicity.
Hypothesis 1b: Serum levels of 8OHdG will be higher in participants with T2D
when compared to those without T2D, independent of ethnicity.
Hypothesis 1c: There will be an inverse relationship between serum levels of
MnSOD and 8OHdG in participants with T2D, independent of ethnicity.
Aim 2: To determine the relationships of serum MnSOD and 8OHdG with various
dietary antioxidants by diabetes status and ethnicity..
Hypothesis 2a: Serum 8OHdG levels will be negatively associated with dietary
intake of antioxidants, independent of diabetes status and ethnicity.
Hypothesis 2b: Serum MnSOD levels will be negatively associated with dietary
intake of antioxidants, independent of diabetes status and ethnicity.
Aim 3: To examine the relationships of glycemic control (A1C) and fasting
plasma glucose levels with various dietary antioxidants in T2D by ethnicity.
Hypothesis 3a: There will be no relationship of A1C with any dietary antioxidants
in T2D independent of ethnicity.
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Hypothesis 3b: There will be no relationship of fasting plasma glucose level and
any dietary antioxidants in T2D independent of ethnicity.

7

CHAPTER II
LITERATURE REVIEW
Oxidative Stress and Diabetes
The literature shows that oxidative stress plays an important role in the
progression of complications associated with diabetes and that there is the potential to
reduce the complications of diabetes via supplementation with antioxidant therapeutics
(Gopaul et al., 2001; Kiss & Szabo, 2005; Rains & Jain, 2011; West, 2000; Ren et al.,
2013). High levels of glucose contribute to an increase in ROS that up-regulates 8oxoguanine DNA glycosylase (OGG1) and decreases superoxide dismutase (SOD)
(Bolajoko et al., 2008). A decrease in serum levels of SOD reduces the efficiency of
neutralizing free radicals, which leads to an induction of mtDNA damage. The result of
the mtDNA damage is an increase in the byproduct 8OHdG (Bolajoko et al., 2008; De
Iuliis et al., 2013).
In the mitochondria, the reverse electron transport chain produces harmful
superoxide radical (O2-) and other ROS (Wen et al., 2013). The body responds to the
production of O2- by up-regulating the antioxidant enzyme SOD in order to neutralize the
oxidizing effects from the superoxide (Ceriello, 2003; Di Naso et al., 2011).
Antioxidants such as riboflavin, n-acetylcysteine, and vitamin E may down-regulate the
production of ROS and assist the body’s antioxidant defensive system, which has
therapeutic implications (Clarke et al., 2008; Cobianchi et al., 2008; Deneke, 2000; Lee et
al., 2013; Landete, 2013).
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Endothelial dysfunction and insulin resistance may result from oxidative stress
(Pereira et al., 2008; Petocco et al., 2010). Additionally, there is a positive relationship of
insulin resistance with 8-epi-PGF2-alpha, an indicator of oxidative stress, among persons
with and without diabetes (Gopaul et al., 2001). Gopaul et al. (2001) also examined
individuals with diabetes who had endothelial dysfunction, assessed by a non-invasive
digital pulse wave photoplethysmography. The finding suggested an increase in arterial
stiffness with the duration of diabetes. There was an increase in 8-epi-PGF2alpha in
subjects with diabetes when compared to controls without diabetes. 8-epi-PGF2alpha
positively correlated with fasting blood glucose, triglycerides, and insulin resistance.
Gopaul et al. (2001) showed that, in T2D, development of endothelial dysfunction and
insulin resistance are preceded by oxidative stress.
Oxidative stress is considered a common pathway for such health conditions as
neurological degenerative disorders, diabetes, and various cancers. A number of studies
have documented the role of oxidative stress in T2D and in MetS in both adults and
children (Abate, Vatansev, & Erkul, 2004; Baines, 1991; Block et al., 2002; Ren et al.,
2013). Ren et al. (2013) observed that ROS may contribute to the T2D by damaging the
normal function of islet β cells via apoptosis of mitochondrial structure. Block et al.
(2002) found that increased fruit consumption correlated with decreased lipid
peroxidation and that the levels of the oxidative stress biomarker malondialdehyde
(MDA) positively correlated with inflammation, as determined by C-reactive protein.
They also found that oxidative stress biomarkers were inconsistent among races; i.e.,
African Americans had higher levels of thiobarbituric acid-reactive substances (TBARS),
no difference in levels of MDA, and lower levels of Iso-P levels as compared to
9

Caucasians. The level of oxidative stress appears to correlate with the degree of
mitochondrial dysfunction in Asian Indians with T2D compared to healthy controls
(Khan et al., 2011).
Khan et al. (2011) studied lymphocytes which were harvested by a density
gradient centrifugation technique and were then used for DNA studies and
immunophenotyping. The researchers used mtDNA/nDNA as a biomarker for the
pathophysiology of the disease. Oxidative DNA damage and cell death were determined
via ELISA. In this way, Khan et al. (2011) examined the role of mitochondrial
dysfunction in immune pathophysiology and were able to identify a strong association
between lymphocytic nuclear DNA damage and T2D as well as an increase in levels of
circulating pro-inflammatory cytokines in subjects with T2D as compared to controls.
Khan et al. (2011) hypothesized that the inconsistency of oxidative stress biomarkers
between ethnicities may be due to differences within an ethnic group. Researchers
normally recruit and classify participants into one group based upon shared distinctive
physical appearance with ancestral origin, such as African Americans, Afro-Caribbean,
and Africans may be classified as Blacks or African Americans. However these ethnic
groups may have large health disparities and different associated risk factors which may
influence the serum levels of oxidative stress biomarkers (VanEenwyk, 2010).
Three factors that contribute to oxidative stress are an increase in oxidant
generation, such as catechols, semiquinones, and reactive quinones; antioxidant
protection degeneration; and oxidative damage repair dysfunction. Free radicals that
contribute to oxidative stress status (OSS) include, but are not limited to, catechol, 2,3
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DHBA, lipid peroxides, reduced glutathione, glutathione peroxidase (GSH-Px), and SOD
(Nelson et al., 2006). Oxidative stress factors may contribute to mtDNA damage inside
the cell. The byproduct of this DNA damage is an endonuclease repair nucleotide called
8OHdG, which is facilitated by an endonuclease repair enzyme (Nelson et al., 2006).
Oxidative Stress and Obesity
Obesity is the accumulation of excessive fat that have been correlated with
increased mortality and health impairment (WHO, 2012). Abdominal fat is a major risk
factor for diseases which are related to obesity and BMI, total body fat and waist
circumference have been shown to be positively correlated with oxidative stress. It is
clear that there is a positive relationship of oxidative stress with obesity, regardless of the
etiology of obesity (Savini et al., 2013).
There is evidence of an increased chance of developing health related diseases
with increasing obesity and BMI, and these findings are higher among some ethnic
groups (Pan et al., 2004; Shai et al., 2006). Since BMI is correlated with oxidative stress
levels and Vimalananda et al. (2011) reported that Haitians had lower mean BMI than
African Americans, determining the relationship between oxidative stress levels in these
two ethnic groups is warranted.
Oxidative Stress and Dietary Antioxidants
It has been proposed that the root cause and complications of T2D is associated
with oxidative stress and that dietary intakes of antioxidants nutrients have been shown to
have beneficial effect on the body’s natural defense mechanisms by inhibiting ROS (Han
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et al., 2007) and preventing mitochondrial dysfunction. Published studies have shown
that accumulated oxidative stress biomarkers and free radicals damages lipid membranes,
DNA and influences insulin resistance and -cell dysfunction (Morris, et al., 2002;
Ceriello et al., 2004; Wright Jr. et al., 2006) and there is growing body of evidence to
support the theory that oxidative stress may be reduced by dietary antioxidant intakes
(Frei, 2004; Siedlak et al., 2009; Mullner et al., 2013 ).
In the review by Frei, a number of studies have shown that dietary antioxidants
such as vitamin C, E, -carotene provide protection against ROS in various biological
systems. He reported that several case-controlled studies have shown an increase in the
DNA oxidation marker, 8OHdG, in subjects with certain types of cancers, cigarette
smokers, and persons with diabetes and suggested that dietary antioxidants may be a
viable therapeutic option. His suggestion was supported by a number of observational
studies that reported an inverse relationship between dietary antioxidant intake and
oxidative DNA damage.
Another dietary antioxidant that has been well studied and has been shown to be
inversely correlated with oxidative stress is vitamin D. It has been reported that vitamin
D deficiency have been correlated with an increased risk of cardiovascular disease and
have been reported to be associated with obesity (Codoner-Franch et al., 2012; Earthman,
et al., 2012; Alemzadeh et al., 2008; Pacifico et al., 2011). Codoner-Franch et al. (2012).
The researchers studied the relationship between relationship of vitamin D and oxidative
stress biomarkers in Caucasians. Overall, these researchers found a significant
relationship of insufficient vitamin D levels and obesity, a risk factor for T2D.
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Similarly, Gradinaru et al. (2012) studied vitamin D status and oxidative stress in T2D
and reported an inverse relationship of vitamin D status with oxidative stress biomarkers.
Siedlak et al. (2009) studied the effect of a diet rich in alpha-lipoic acid in a
mouse model expressing amyloid- protein precursors. The oxidative stress biomarkers
used in this study was heme-oxygenase -1 and 4-hydroxynonenal. The researchers
reported a significant decrease in the level of these oxidative stress biomarkers in the
animals fed the diet of alpha-lipoic acid compared to wild-type mice which served as
controls.
Mullner et al. (2013) studied the effect of vegetables and PUFA-rich plant oils on
DNA strand breaks in T2D subjects. Diabetes and non-diabetes participants were
assigned to either a intervention or control group. Participants from the intervention
group were provided vegetable rich and PUFA-rich oils. Blood samples were collected at
baseline, and at 4, 8, and 16 weeks and oxidative stress assessment was conducted to
determine DNA damage in mononuclear cells. The study showed that participants with
diabetes had statistically significant reduced levels of DNA strand breaks and it appears
that the healthy oils provided some protection to the DNA in the participants with
diabetes.
Other research provided evidence of an association between diet and oxidative
stress and the possible role of dietary antioxidants in the reduction of complications
associated with T2D. Additionally, some foods may have powerful antioxidant
properties which have been reported to have health benefits such as the Mediterranean
diet (Savini et al., 2013). The effect of this diet on health conditions is related to the
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dietary benefits from fruits, vegetables, whole-grains, nuts, fish, moderate wine
consumption and olive oil. A study by Ortega-Azorin et al. (2012) provided evidence
that dietary patterns were more beneficial than specific foods and that adherence to one
such dietary pattern, the Mediterranean diet, provided the health benefits of a high quality
diet.
The dietary intake of antioxidant foods or supplements may reduce oxidative
stress and, subsequently, lessen mtDNA damage (Weissenberger et al., 2010). Generally
it is believed that the identification of dietary factors that play a key role in the protection
of the mitochondria and the alleviation of symptoms associated with diabetes is crucial to
the development of preventive measures. Due to the variability in ethnic dietary choices
and food preparation, it is important to determine whether there are ethnic differences in
oxidative stress biomarkers and mtDNA damage. There are few published studies on the
relationship of antioxidant nutrient intake and mtDNA damage among different ethnic
groups. This study identified the differences in dietary intakes of antioxidants for African
Americans and Haitian Americans and also investigated the relationships between the
dietary antioxidants and oxidative stress biomarkers.
Oxidative Stress and Biochemical Mechanism
There is convincing clinical and experimental evidence of the biochemical
mechanism of oxidative stress. Experimental evidence establishes that there is a
significant reduction in glutathione levels and erythrocyte CuZn-SOD activity in
individuals with diabetes, with or without cardiovascular disease (CVD) (Chen, Osio, &
Anderson, 1999; Chatuphonprasert et al., 2013). The underlying mechanism of oxidative
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stress is a reduction of oxygen (O2) that can have reversible or irreversible effect on cells,
organs, or tissues. This biochemical effect results from intermediate compounds that are
produced from the reduction of O2, which produces O2-, hydrogen peroxide, and hydroxyl
anions.
There is strong evidence that oxidative stress is increased by several physiological
conditions such as hyperglycemia, exposure to environmental pollutants, and the
generation of ROS by DNA during its normal biochemical functions (Poljsak & Fink,
2014). Oxidative Stress may also be generated from different sources in the body such
the oxidation of polyunsaturated fatty acid (PUFA; West, 2000; Bae et al., 2011) and
calcified regions of stenotic aortic valves and atherosclerotic arteries (Miller et al, 2008).
In the mitochondrial membrane, ROS is generated during the production of
nicatinamide adenine dinucleotide phosphate (NADPH) and catalyzed by the enzyme
NADPH oxidase (Bae, 2011). There are two biochemical pathways for the production of
NADPH. The first pathway is the hexose monophosphate shunt, where the insulininduced enzyme glucose-6-phosphate-dehydrogenase (G-6PD) is required to oxidize
glucose-6-phosphate (G-6P) to produce 6-phosphogluconate. The second pathway is
driven by another insulin-dependent enzyme, 6-phosphogluconate dehydrogenase (6PGD), to oxidize 6-phosphogluconate, which produces more NADPH. The enzyme
isocitrate dehydrogenase (ICD) is critical to the oxidative decarboxylation of isocitrate to
alpha-ketoglutarate, utilizing either NAD+ or NADP+ as cofactors. In a rat model,
superoxide dismutase (SOD) inactivates the NADP-dependent isocitrate dehydrogenase
(ICD), resulting in a statistically significant reduction in ICD activity (Batini-Haberle &
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Benov, 2008). Since NAD+ and NADH+ are both key components of cellular respiration
and energy metabolism, then a reduction in ICD activity would profoundly affect
apoptosis and increase oxidative stress levels.
Batini-Haberle & Benov (2008) studied the reduction in ICD activity levels and
found that it was due to the neutralizing and reducing effects of SOD on the production of
NADPH. NADPH, a reducing agent, is involved in immunological reactions in immune
cells and in respiratory burst reactions where there is a production of ROS. A similar
mechanism is observed in immune response to the presence of bacteria or fungi in the
blood stream (Omori et al., 2008). In persons with diabetes, it is observed that
neutrophils which participate in the respiratory burst require priming by NADPH oxidase
(Omori et al., 2008). Abnormal insulin production will impair the hexose
monophosphate shunt and reduces the rate of NADPH production. This reduction in
NADPH influences the oxidative defense systems, e.g., the glutathione peroxidase and
catalase enzymatic system (Bono, 1987). This is because NADPH plays a crucial role in
the activities of enzymes such as catalase and SOD, which are anti-oxidative defense
systems whose function is to reduce ROS. The effect of the impairment is the elevation
of the levels of serum ROS, which results in oxidative cell damage (Bono, 1987).
Miller et al. (2008) studied the biochemical mechanism that may contribute to the
stenotic aortic valves and atherosclerotic arteries and he found that a major contributor is
the activity of uncoupled nitrous oxide species (NOS). In addition, uncoupled nitrous
oxide contributes to the production of superoxide and ROS and may assist in the
disruption of cell membranes, proteins, lipids, and cellular constituents. The
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mitochondrion is a cellular component that is responsible for a vast majority of ROS
production (Bae, 2011).
Diabetes and Manganese Superoxide Dismutase (MnSOD)
The major defense from free radical damage in the mitochondria is provided by
the manganese superoxide dismutase (MnSOD), which is an enzyme unique to the inner
mitochondrial space (Curtis et al., 2007). Manganese superoxide dismutase is regarded
as the most powerful enzyme in the defense against active oxygen species, producing
hydrogen peroxide and oxygen (Curtis et al., 2007). The mitochondria are the source of
superoxide, which has been shown to be a major contributor to the progression of
diabetes complications in persons with diabetes (Kowluru et al., 2006).
There is evidence that MnSOD may provide protection to diabetic
cardiomyopathy in a diabetic mouse model by reducing ROS and improving
mitochondrial function (Shen et al., 2006). The researchers identified that ROS
participate in diabetes-induced heart muscle apoptosis, and they reported that this
pathology was preventable with adequate antioxidants.
Manganese superoxide dismutase (MnSOD) is an enzyme that is encoded by a
single-copy gene. Its expression is controlled by the GC-rich promoter region that
contains numerous specificity protein 1 (SP-1) and activating protein 2 (AP-2) binding
sites (Hitchler, Oberley, & Domann, 2008). Hitchler et al. (2006) have shown that the
MnSOD expression is regulated by epigenetic factors rather than just variations in DNA
sequence. This enzymatic regulatory mechanism may provide an explanation of the
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reduction in MnSOD enzyme activity and that its production is influenced by both
genetic and environmental factors (Hitchler et al., 2006).
Madsen-Bouterse, Zhong, Mohammad, Ho, and Kowluru (2010) conducted
research on retinal endothelial cells and found evidence for the protection of
mitochondrial DNA by the nuclear specific enzyme MnSOD. The researchers examined
the DNA damage caused by hyperglycemia using a q-PCR method and identified the
genes which were expressed using RT-PCR methodology. Madsen-Bouterse et al. (2010)
found that there was an increase in mtDNA damage in retinal endothelial cells which
were exposed to hyperglycemia and that MnSOD play a significant role in preventing
mtDNA damage. A similar protective role of MnSOD on mtDNA damage was reported
by Sadi, Eryilmaz, Tutuncuoglu, Cingir, and Guray (2011). In another study (Zhong &
Kowluru, 2011) that used rats, the results indicated that hyperglycemia reduced MnSOD
activity, which, in turn, resulted in a 60% decrease in gene transcription. Overall, there
are few studies that examine the relationship between MnSOD and mtDNA damage, and
most were conducted using cell cultures or animal models. Because these experimental
designs used animals, it is not known whether the results are generalizable to humans.
In an animal study, Kowluru et al. (2006) investigated the effects of diabetes
complications in MnSOD-transfected rats. Wister rats were caused to be diabetic with
the use of streptozotocin and were maintained as such through the 11-month duration of
the study. The control group of transfected rats was fed a diet that was void of the
antioxidant lipoic acid, while the experimental group had a diet that was supplemented
with lipoic acid. Both groups were fed for 11 months, after which time they were
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sacrificed, and the retina was harvested and serum was collected and stored for analytical
studies. The researchers used commercially available ELISA kits to determine MnSOD
activity and 8OHdG levels; they also determined the development of retinopathy by
pathological examination of the harvested retina. They observed an increase in the level
of MnSOD and the progression of diabetic retinopathy in MnSOD-transfected rats when
compared to the non-transfected rats.
In the same study Kowluru et al. (2006) also examined the effect of lipoic acid
therapy on the MnSOD activity in the rats with diabetic retinopathy. They found a
significant decrease in the enzymatic activity of MnSOD within the mitochondria of
diabetic rats compared to rats without diabetes. In addition, there was similar cytosolic
SOD activity between diabetic rats and non-diabetic rats. A statistically significant
increase in the MnSOD level in the plasma of rats that consumed diets with lipoic acid
was also found. They concluded that there was a decrease in oxidative stress in the lipoic
acid-supplemented group, as determined by a decrease in 8OHdG level.
Garcia-Ramirez et al. (2008) have shown that subjects with diabetes, with or
without CVD, had significantly reduced SOD activity when compared to a control group.
The participants with diabetes were in the late stages of diabetes complications.
Mitochondrial DNA was then determined via a real-time peripheral blood mononuclear
cells (PBMC). MnSOD activity was determined from homogenized PBMC via an assay
that measured inhibition of the reduction of cytochrome C by moving oxygen.
Mitochondrial DNA damage and mitochondrial content were used as indicators of the
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degree of oxidative stress. MnSOD activity was used as a mitochondrial antioxidant
defense index.
Mitochondrial DNA damage was significantly greater in the subjects with
diabetes than without diabetes. MnSOD activity was significantly increased in the
peripheral blood mononuclear cells (PBMC) of persons with T2D, as compared to the
controls without diabetes. The researchers concluded that the increased MnSOD activity
was due to an adaptive response to oxidative stress. Overall, the results showed that there
was a reduction in mtDNA damage due to the degree of mtDNA oxidation (a result of
oxidative stress) and that MnSOD was up-regulated as a response to the oxidative DNA
damage.
The literature shows that there is an inverse relationship between serum MnSOD
levels and T2D complications; i.e., the over production of serum levels of MnSOD levels
were observed in subjects with diabetes complications as compared to subjects without
diabetes complications. There is accumulating evidence that mitochondrial substrate
sensitivity is increased in the skeletal muscle of subjects with T2D when compared to
subjects without T2D. A decrease in mitochondrial substrate sensitivity correlates with
reduced extracellular MnSOD levels (Larsen et al., 2011). In addition, it appears that
mitochondria do not function efficiently in the skeletal muscle of subjects with T2D, and
the size of the mitochondria, as measured by electron microscope, is smaller than that
seen in a control group (Kelley, He, Menshikova, & Ritov, 2002).
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There were no recent studies found in the literature that evaluated the relationship
between the serum levels of MnSOD and either African American or Haitian American
subjects with and without T2D.
Diabetes and 8-hydroxy-2’-deguanosine (8OHdG)
Diabetes contributes to numerous health complications such as neuropathies,
blindness, and macular degeneration. The major mechanisms that cause the
complications are the activation of protein kinase C (PKC), advanced glycation end
products (AGE), and an increase in polyol and hexosamine pathway flux (Rolo &
Palmeira, 2006). The progression of diseases which are associated with T2D may be due
to mutations in the mtDNA and mtDNA copy reduction. Rolo and Palmeira (2006) have
shown an association between the mitochondrial nuclear-encoded glucose transporters,
glucose-stimulated insulin secretion, and nuclear-encoded uncoupling proteins.
One of the effects of oxidative stress is the damage to the mitochondria. The
damage is associated with an increase in mitochondrial reactive oxygen and the
generation of nitrogen species, i.e. Nitrogen oxide. MnSOD plays a key role in the
protection of the mtDNA damage from oxidative stress (Li & Zhou, 2011). Lumini,
Magalhaes, Oliveira, and Ascensao (2008) stated that the dysfunction of the mitochondria
produces reduced uncoupling proteins (UCPs). UCPs are located in the inner membrane
of mitochondria that function as transporters. UCP1 is predominantly found in brown
adipose tissue and is involved in respiration, UCP2 is ubiquitous and is highly expressed
in the lymphoid system, and UCP3 is solely expressed in skeletal muscle and heart. The
UCP2 that is expressed in the pancreas has been linked to hyperinsulinemia (Fleury et al.,
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1997). In addition, under-expressed UCP2 is associated with a reduction in glucoseinduced insulin secretion (Saleh, Wheeler, & Chan, 2002). Lumini et al. (2008) indicated
that exercise may reverse the mitochondrial defect, but the mechanism by which this
occurs is not clearly understood. This finding was corroborated by Jun et al. (2009) in a
study of male and female Koreans between the ages of 20 and 70 years. From the 1,500
subjects, the researchers collected data on dietary intake, physical activity,
anthropometrics, and biochemical analysis, including single-nucleotide polymorphism
genotype, using fasting blood specimen. Low physical activity was correlated with
under-expression of UCP2, BMI, and waist circumference. The polymorphism in the
UCP2 gene was related to T2D.
In hyperglycemic subjects, elevated levels of oxidative stress contribute to the
progression of diabetes complications. Research has shown an association between
diabetes complications and mitochondrial DNA damage (Madsen-Bouterse et al., 2010;
Kowluru et al., 2006). The effect of oxidative stress on the mitochondria is evidenced by
an increase in the conversion of deoxyguanine (dG) to 8OHdG in DNA (Suzuki et al.,
1999; Xu et al., 2004). Suzuki et al. (1999) investigated mtDNA4977 deletion in muscle
DNA and 8OHdG content in diabetes and found that there was an increase in deltamtDNA4977. The study showed that an increase in mtDNA4977 was proportional to the
severity of the diabetes complications. The study also showed that increased 8OHdG was
related to the severity of diabetes complications (Suzuki et al., 1999). The mechanism of
DNA damage appears to be directly associated with oxidative stress and defects in the
mitochondrial oxidative phosphorylation (Lee & Pervaiz, 2011; Suzuki et al., 1999).
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Diabetes and Diet
According to the National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDKD), the improvement of the quality of the diet may reduce the risk of
T2D by lowering blood glucose and cholesterol levels, lower BMI, and in some cases it is
preventable by early detection of insulin resistance and subsequent high quality dietary
intervention. In persons with T2D, the risk of T2D may be reduced by including daily
exercise and physical activity, abstaining from smoking and alcohol, and maintaining a
healthy weight, and dietary management (Martin-Timon et al., 2014; ADA, 2013; Izandi
et al, 2013). Of these cofactors of T2D, dietary management is probably the most
difficult therapeutic intervention for individuals with T2D (Evert at al., 2014).
Several studies have demonstrated that T2D may be prevented with dietary
modifications and lifestyle changes (Bazzano, Serdula, & Liu, 2005; Caro, Ward, &
O’Brien, 2002; O’Brien et al., 2000; Tuomilehto et al., 2011). According to Bazzano et
al. (2002), the development of T2D may be influenced by a combination of
environmental factors, such as low dietary fiber and high fat intakes, high glycemic index
and high glycemic load of the diet, being overweight or obese, and physical inactivity.
Tuomeliheto et al. (2011) observed that T2D may be prevented when several lifestyle
targets were followed, such as loss of weight, decrease fat intake, increase dietary fiber
intake, and increased physical activity. Participants who followed a healthy diet had
favorable health outcomes.
A healthy diet is defined as being of high quality when it includes whole grains,
healthy fats and proteins, unrefined foods, and fruits and vegetables (Akbaraly et al.,
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2011; McCullough et al., 2002; Larsen et al., 2010). Harvard School of Public Health
provided evidence that eating more whole grains, fruits, and vegetables will reduce the
risk of T2D by 20 percent (ADA, 2014). In this study, the researchers determined the
quality of diet with the use of the 110-point Alternate Healthy Eating Index 2010.
The inability to follow a recommended high quality diet may be influenced by
ethnic culture, lifestyles, and beliefs (Anderson-Loftin et al., 2005). African Americans
(Liburd, 2003) and Haitian Americans may find it challenging to follow a high quality
diet because of cultural and ritualized nature of food choices and socio-economic status
(Huffman et al, 2013). The adherence to a high quality diet has been shown to influence
glycemic control in African American women with T2D (Skelly et al., 2009) and thereby
the possible delay of the onset of complications (ADA, 2013).
The effect of diet and environmental factors on the progression of disorders
associated with T2D has been well documented (Kallio et al., 2007; Tuomeliheto et al.,
2011). In the Kallio et al. (2007) study, participants had a body mass index (BMI)
(Kg/m2) of 26-40, were between the ages of 40 and 70, and satisfied at least three criteria
for a diagnosis of MetS, using National Cholesterol Education Program (NCEP, 2011)
guidelines. The researchers examined the effect of a carbohydrate-modified diet on gene
expression in abdominal subcutaneous adipose tissue and on glucose and insulin
metabolism (Kallio et al., 2007A diet comprised of rye-pasta influenced gene expression
by down-regulating genes linked to insulin signaling, which resulted in a 21% decrease in
the cell size of adipocytes (Kallio et al., 2007). A diet that consisted of oat-wheat-potato
appears to activate the genes that are associated with inflammation and oxidative stress,
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without any observable change in adipocyte cell size (Kallio et al, 2007). The researchers
established that the type of dietary carbohydrate played an important role in modulating
gene expression.
Serum Levels of MnSOD and Oxidative Stress
The literature reports experimental and clinical findings of a link between
MnSOD, oxidative stress and impaired mitochondrial function in diabetes. MnSOD is
localized in the mitochondria and serves to protect the mtDNA from oxidative stress
damages (Li & Zhou, 2011). The damages to the mtDNA can impair the functions of
cells (Garcia-Ramirez et al., 2008) and contribute to progressive disorders associated
with diabetes. Although serum level of MnSOD is well documented in subjects with
cancers (Lin et al., 2005; Nishida et al., 1993; Schadendor et al., 1995) and
cardiovascular disease (Shen et al., 2006; Miriyala et al., 2011), the data for T2D is
sparse and the clinical significance of serum MnSOD is yet to be determined. The data
on serum MnSOD levels in T2D would provide information that may be used to guide
and monitor dietary antioxidant intakes as a means to reduce oxidative stress (GarciaRamirez et al., 2008).
The enzyme MnSOD reduces oxidative stressors; however, it is well documented
that the plasma levels of SOD in patients with T2D diabetes is markedly reduced (GarciaRamirez et al., 2008). Abnormally low levels of SOD may contribute to mtDNA damage
(Garcia-Ramirez et al., 2008). A possible therapeutic approach to reduce or slow the
mtDNA damage caused by oxidative stress is to improve the plasma levels of MnSOD,
which can be accomplished through the use of hormones such as HCG or melatonin
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(Kozirog et al., 2010) as well as through antioxidant micronutrients such as copper,
selenium, and manganese (Otsu, Ikeda, & Fujii, 2004).
Kozirog et al. (2010) treated diabetes subjects with 5 mg of melatonin. The
subjects were instructed to take one capsule of melatonin before bedtime for a period of
60 days. Blood pressure (BP) and a fasting blood specimen were taken to establish
baseline data, including serum lipid profiles and oxidative stress biochemical markers
such as TBARS, SOD, and glutathione peroxidase (GSH-Px). After a 2-month
intervention period, BP and blood sample were taken for the determination of the effect
of the melatonin intervention. The researchers observed a significant improvement in
blood pressure, lipid profiles, and glutathione.
The effect of mineral supplements on SOD enzymatic activity levels has shown
positive influences, including the improvement of catalase enzymatic activity, another
antioxidant enzyme (Kozirog et al., 2010; Beauchamp & Fridovich, 1971). HepG2 cell
lines are hepatocellular carcinoma-derived cells that are conventionally used to conduct
in-vitro studies of the mechanism that occurs in liver cells. The researchers studied the
effect of supplements, which were either replenished or depleted, of a mineral of interest.
Supplements with or without Cu and Zn, which were used to feed the cell lines, and SOD
activity was determined (Beauchamp & Fridovich, 1971; Otsu et al., 2004). Mineral
depletion appeared to down-regulate both Cu/ZnSOD and MnSOD to 70%-80% of
baseline activity level. Zn was shown to be more critical than Cu in the up-regulation of
MnSOD, which may be due to Zn’s involvement in MnSOD induction (Otsu et al., 2004).
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Further research is needed to evaluate effect of antioxidants supplementation on plasma
levels of MnSOD and on mtDNA damage.
Serum Levels of 8OHdG and Oxidative Stress
Oxidative stress has been implicated in a number of diseases, including cancers
and Type 2 Diabetes. It is clear that 8OHdG is an oxidative stress biomarker found to be
elevated in patients with diabetes and may contribute to diabetes complications (Pan et
al., 2008; Al-Aubaidy et al., 2011). Clinical studies show that serum 8OHdG is
measurable by ELISA method and proven to be a reliable biomarker for oxidative DNA
damage (Basavarai, et al., 2013; Pagano, et al., 2014).
The acceptable specimen for the determination of 8OHdG levels are serum, cell
lysate, peripheral blood mononuclear cells, and urine (Chen et al., 2008). Urine samples
for 8OHdG testing require 24-hour urine collection, and it is demanding on the subject
involved in the collection process (Khadem-Ansari et al., 2011). The predominant
biomarker that is used to assess the degree of mtDNA damage is 8OHdG and the
accumulation of 8OHdG in serum has been reported in patients with T2D (Jamil et al.,
2014). Recently, a number of 8OHdG ELISA test kits have been validated for serum
specimens and the test kits have documented performance characteristics such as
sensitivity, specificity, and inter- and intra-assay reproducibility. Akihiko, Odamaki, and
Hishida (2003) have shown that the serum level of 8OHdG, using ELISA test kits, was
significantly higher in subjects with diabetes, as compared to subjects without diabetes.
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Oxidative Stress and Glycemic Control among Ethnic Groups
Emerging literature shows that all Blacks should not be grouped together and
identified as African Americans (Huffman et al., 2011; Huffman et al., 2013).
Feairheller, Diaz, Sturgeon, Williamson, and Brown (2011) examined total antioxidant
capacity (TAC), protein carbonyls (PC), and TBARS among African Americans and
Caucasians. They found that, even though there were no statistical differences between
African Americans and Caucasians for age, BMI, or blood pressure (diastolic and
systolic), there were statistically significantly higher levels of oxidative stress in African
Americans. To examine the effect of geographical influences on oxidative stress, Deeq et
al. (2008) conducted a cross-sectional study that included African Americans from
Indianapolis, Indiana, and Yoruba from Nigeria. The researchers used 8-Isoprostane as
the biomarker for oxidative stress. They found evidence of higher oxidative stress levels
in Nigerians, which may be dietary and environmentally influenced.
Research has shown that diabetes, high blood pressure, and other cardiovascular
disease (CVD) risk factors affect African Americans more than they do Caucasians
(CDC, 2011; Liutkeviciene, Lesauskaite, Asmoniene, Zaliuniene, & Jasinskas, 2010).
One of the most important independent risk factors for the progression of complications
associated with diabetes is hemoglobin A1C (O’Connor et al., 2011). Morbidity and
mortality are highest in African Americans with peripheral artery disease (PAD). A
meta-analysis (Kirk et al., 2013), examined glycemic control as measured by A1C and
found that African Americans values were more elevated than non-Hispanic whites with
diabetes. The authors reported that the observed disproportionate A1C levels between
African Americans and non-Hispanic whites may be due to access to medical care, less
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optimal diabetes care, and medication affordability (Karter et al, 2002; Rhee et al., 2005;
Kirk et al., 2005; Ofili, 2001). This may be related to the lack of agreement of the
correlation between A1C and average glucose in certain subjects (Standards of medical
care in diabetes, 2014). Glycation rates may be race dependent, consequently A1C levels
may have ethnicity variability (Ziemer et al., 2010; Kumar et al, 2010). Glycation
involves oxidative reactions that may adversely affect DNA function (Pun & Murphy,
2012). Since glycation rates could be dependent on ethnicity, then oxidative stress levels
could cause a higher rate of DNA damage in subjects with T2D. There is evidence of a
strong inverse correlation between DNA damage, oxidative stress, and apoptosis with
levels of A1C (Khan et al., 2011), providing a measure of the average blood glucose level
over 2-3 month period. Subjects whose diabetes status is out-of-control are more likely
to developed diabetes complications. It is well documented that glycemic control
influences the extent of oxidative stress (Marling, Shubrook, Vernier, Wiley, & Schwartz,
2011; Nahkjavani et al., 2010) and that A1C is a reliable biomarker and indicator of
glycemic control.
Ethnicity and Dietary Antioxidant Intake
The literature on dietary antioxidants intake is varied and not conclusive.
Suksomboon, Poolsup, and Sinprasert (2011) reviewed nine randomized clinical trials on
vitamin E supplementation and glycemic control in subjects with T2D but found no
significant changes in A1C levels as a result of supplementation with vitamin E. In a
study by Camargo et al. (2006), subjects with T2D were administered pharmacological
dose of vitamin E supplements over a 4 month period and it was observed that it did not
impact A1C. Alternatively, in a review by Unnikrishnan et al. (2012), it was reported
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that high doses of Vitamin C and E have lowering effect on A1C. In their review, they
reported that the mechanism for the lowering effect of A1C is related to the reduction in
the rate of hemoglobin glycation. Arab et al. (2011) compared dietary antioxidant intake
between African Americans and Caucasians. They found that healthy African Americans
were more likely to be overweight and that being overweight contributed to inflammation
and oxidative stress status. In addition, they found that 32% of African Americans, as
compared to 45.2% of Caucasians, took dietary supplements. Overall, they found a
significant correlation between dietary antioxidant intake and plasma concentrations of
carotenoids as determined by high-performance liquid chromatography (HPLC). African
Americans had a significantly lower intake of antioxidants. The researchers believed that
the difference may have been due to food preparation, dietary sources, genetic variants,
or BMI (Arab et al., 2011). Huffman, Serge, and Himburg (2011) found intra-racial
differences in caloric intake and BMI in African Americans and Haitian Americans.
Manganese (Mn) is an important antioxidant that scavenges free radicals and is
secondary to biochemical functions, behaving as a backup free radical scavenger that is
similar to MnSOD, especially in regard to oxidative stress (Reddi & Culotta, 2011).
Although there is a lack of data on the mechanism by which Mn participates in the
cellular adaptation to oxidative stress (Reddi & Culotta, 2011), research has shown that
the antioxidant activity is regulated by nutrient-sensing pathways.
The data from published works shows that diabetes status influences manganese
physiological status by various etiological factors such as viral infection, autoimmunity,
genetics, and obesity (Walter et al., 1991). The mechanism which may influence the
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manganese status in diabetes may be related to dysfunction in mineral metabolism
(Walter et al., 1991). It is well documented that Mn, an essential component of the
enzyme MnSOD (Greger, 1998). Hope et al. (2006) reported that dietary Mn intakes
were lower in non-tea drinkers compared with tea drinkers and that tea is a major source
of dietary Mn. In their study, the levels of MnSOD were determined via RT-PCR from
blood collected from volunteers who were assigned to either a tea-drinker and non-tea
drinker group. This study showed that dietary Mn intake can improve the Mn status in
the body and that there was an inverse relationship of Mn plasma levels and MnSOD of
leucocytes.
The literature indicates an overwhelming evidence of the negative influence of
oxidative stress and MnSOD in inflammation and cancer (Fu et al., 2011; Li et al., 2011;
Suzuki et al., 2001). Because Mn and iron (Fe) play an important role in the biosynthesis
of MnSOD (Hassan & Schrum, 1994), data on the dietary intake of Mn may provide
valuable information on possible biochemical requirements for the production and upregulation of MnSOD. There is some evidence that vitamins and minerals play an
important role in slowing the progression of disease associated with T2D (Martini et al.,
2010) and reducing oxidative stress levels.
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CHAPTER III
METHODOLOGY
Study Design
This study used a cross-sectional design to explore the relationship between two
biomarkers that are closely linked to oxidative stress and the biomarkers’ relationship to
diet and disease state. The data and specimens that were used for this study were
collected previously (Huffman et al., 2007). This study was conducted with Haitian
Americans and African Americans with and without T2D. The investigator of this study
fully participated in data collection. After the participants signed an informed consent
form, they were assigned a unique identifier, and blood was collected and processed
immediately and stored for analysis at a later time by this investigator. The unique
identifier was the only link between the participants’ demographic information and
laboratory assessment. The participants’ personal information, as linked with the unique
identifier, was kept in a locked cabinet. This study was approved by the Institutional
Review Board at Florida International University’s Office of Research Integrity under
IRB exemption number 073112-01 (Appendix E).
Anthropometric Measurements
Participants had their height, weight, and waist circumference recorded by a
trained research assistant. Measurements for height and weight were obtained by using a
SECA balance scale (Seca Corp., MD, US). Waist circumference was measured
horizontally with a measuring tape. The participants completed a standardized sociodemographic dietary assessment questionnaire (FFQ) and a medical questionnaire that
included medical history, prescribed medications, and the use of supplements. The
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control group participants (without T2D) underwent the same procedures as did the
participants with T2D. This was a cross-sectional study that used data from male and
female participants, aged 35 years or older, with and without T2D. Ethnicity (Haitian
American and African American) and diabetes status (T2D or no diabetes) were selfreported but verified by blood test.
Recruitment of Participants
Participants were initially recruited by randomly generated mailing lists
purchased from Knowledge Base Marketing, Inc., Richardson, TX, U.S. This company
provided two mailing lists generated from multiple databases of African Americans,
identified as having or not having T2D, from Miami-Dade and Broward Counties,
Florida, U.S. Approximately 7,550 letters were mailed to African American participants
with and without T2D. Approximately, 6.3% (n = 477) of the letters were returned due to
an invalid addresses. From the remaining delivered letters, 4% (n = 256) responded
(Figure 1).
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Figure 1 – Recruitment of African American Participants
Returned,
n=477, 6.3%

Responded,
n=256, 4.0 %

Mailed, 7550

1. Local diabetes educators and community health practitioners in Miami-Dade and
Broward Counties. Several local diabetes educators who were either former
students or who were in close contact with the Department of Dietetics and
Nutrition at Florida International University (FIU) were identified. Letters of
invitation, which described the study, were mailed to the diabetes educators and
health professionals in Miami-Dade and Broward counties and requested their
cooperation in recruiting individuals.
2. FIU faculty, staff, and students. Invitational flyers were distributed to all
university faculty, staff, and students who used the university-wide e-mail system;
these flyers contained an explanation of the research protocol and requested their
assistance in the study.
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3. Several residential and rental facilities were used to conduct interviews and
complete questionnaires.
4. Advertisements. Print advertisements were placed in local Haitian newspapers
and the principal gathering places of these groups, such as churches,
supermarkets, and restaurants. Radio advertisements on local Creole stations also
were aired.
When the target recruitment goal was reached for all ethnic groups, efforts to
recruit participants were discontinued. Interested participants were initially interviewed
on the phone, at which time the study’s purpose was explained and the age, gender and
ethnicity of the responders were determined. To ascertain T2D status, each participant
who self-reported as having diabetes was asked for the age of diagnosis and initial
treatment modalities. Participants who did not qualify for the study (N = 28) consisted of
those who were younger than 35 years old (N = 12), another ethnicity (N = 5), or who
had other chronic diseases or illnesses (N = 11). If a potential participant was determined
to be eligible, then his or her participation was requested at the Human Nutrition
Laboratory at FIU. Participants were instructed to refrain from smoking, consuming any
food or beverages except water, and engaging in any unusual exercise for at least eight
hours prior to their blood collection.
The study was approved by the Institutional Review Board at FIU. The purpose
and the protocol of the study were explained to the participants, and their written consent,
in either English or Creole, was obtained prior to the commencement of the study.
Laboratory results showed that 12 participants (Haitian American = 8, African American
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= 4) who reported as not having diabetes were reclassified as having T2D, according to
American Diabetes Association standards. These participants were given their laboratory
results, referred to their physician. A total of 443 (234 Haitian American, 209 African
American) participants were included in the final data analysis.
Sample Size and Power Analysis
In this study, multiple linear regressions were the primary statistical analysis
method used. It was necessary to determine the sample size for an independent variable
(e.g., total antioxidants) added to the equation explaining an additional 1.6% of the
variability of the dependent variable (e.g., serum MnSOD levels) after controlling for
eight covariates. Using a sample size calculator for multiple regression (GPower3, 2010,
Faul et al, 2009) with eight covariates and a partial R2 of 0.18 for the added predictor,
80% power, and a 5% significance level, a sample size of 431 participants was necessary.
The main study had enrolled 515 participants, and had complete data on 443 participants.
This study was sufficiently powered for the statistical analysis.
Compliance
A fasting specimen is an important requirement to the assessment of the
biomarkers that were evaluated in this study. To ascertain that the subjects were
compliant with at least an 8-hour fast, they were asked to fill out a questionnaire that
included an item regarding fasting, and the researcher asked the participant about his or
her fasting compliance. In addition to a fasting glucose analysis (to verify fasting), the
researcher determined the level of glycosylated hemoglobin A1C. Hemoglobin A1C was
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used for analysis of diabetes self-management and to help determine the presence of
T2D.
Nutritional Assessment
Dietary intake of calories and nutrients were measured using the semi-quantitative
food frequency questionnaire (FFQ; 97GP 2006 version copyrighted at Harvard
University, Boston, MA, U.S.), which has been extensively validated and standardized in
several multiethnic population-based studies (Willet et al., 1985). On the FFQ,
participants self-report average consumption of specified amounts of various foods over
the past year, with response categories that ranged from “never” to “six or more servings
per day.” In addition to food items, the FFQ included questions about type and duration
of vitamin/mineral supplement use and specific details about fat, salt, and sugar used in
cooking and as condiments. Each of the completed FFQs was reviewed for incomplete
answers or blank responses before the interview was completed. Researchers completed
the incomplete items by probing of the subjects before they left.
Daily servings for food groups were calculated by summing the frequency factors
for all related food items. Macro- and micro-nutrient intakes were calculated by
multiplying frequency of consumption by the nutrient value of the food item, as obtained
from the Harvard University Food Composition Database (Willet et al., 1985). The
calculated consumption of dietary antioxidants was used to determine the relationship
between MnSOD and 8OHdG and antioxidants intakes.
Blood Collection and Biochemical Assessment
Participants were asked to fast for at least 8 hours before blood was collected by a
certified phlebotomist. Blood was collected by venipuncture into serum separator tube
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(SST) and ethylenediaminetetraacetic acid (EDTA) tubes. Fasting Plasma Glucose levels
and A1C were measured from the blood which was collected in the EDTA tube by
Laboratory Corporation of America, Miami, FL (LabCorp®). Twenty milliliters of
fasting venous blood was collected in serum separation tubes, centrifuged, and processed,
and aliquots were stored in a -70° Celsius freezer by the researcher of this study.
Biochemical studies were performed to determine total cholesterol, triglycerides, lowdensity lipoprotein, and high-density lipoprotein via a methodology from Cobas Mira,
Roche Diagnostics (Bowling & Katayev, 2010). Glucose levels were measured using the
hexokinase enzymatic method, and a monoclonal antibody method (Bayer Corporation,
Diagnostic Division, Tarrytown, NY, USA) was used to determine glycated hemoglobin
(A1C). Participants were provided with a copy of their biochemical assessment,
including a cardiovascular risk analysis which was calculated from the lipid profile.
Serum levels of MnSOD and 8OHdG were determined. ELISA was used as the
method of detection of these biomarkers. Presently, there are numerous ELISA kits
available that can detect the levels of 8OHdG in serum. There has been good correlation
between plasma levels of 8OHdG and tissue 8OHdG by this method (Park et al., 2001).
These correlations support the use of plasma levels of 8OHdG to predict the degree of
mtDNA damage.
The gold standard for the identification of 8OHdG in tissue, blood, and urine is
high-performance liquid chromatography tandem mass spectrometry (HPLC-ms), which
is as effective as the more readily available high-performance liquid chromatographyelectrochemical (HPLC-EC) detection methodology (Harri et al., 2007). These methods
require expensive equipment, analytical software, and highly skilled operators. The
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availability of monoclonal antibodies to 8OHdG, however, provided a framework for the
development of a method of detection (ELISA) that is cheaper, requires less costly
equipment and reagents, and does not require highly trained experts to perform and
analyze specimens. The ELISA kit platform is reliable, reproducible, and validated for
the detection of 8OHdG in urine, cell lysates, and serum. In several studies, ELISA has
been shown to be as effective as HPLC (Breton et al., 2003; Yoshida et al., 2003).
Several manufacturers have developed highly sensitive 8OHdG ELISA kits that require a
pretreatment of serum before performing the analysis.
In this study serum MnSOD was detected via the ELISA method. The literature
search for the rational in determining MnSOD in serum in T2D is missing, however the
evidence is convincing that serum levels of MnSOD is a useful tool and potential clinical
biomarker to predict disease associated with viruses (Tamai et al., 2011), and cancers
(Schadendor et al., 1995; Nishida et al., 1993). The reagents were available on the open
market and they were purchased from Cayman Chemicals (Ann Arbor, MI). The assay
also requires a plate reader with a 450-nm reading capacity. All supplies and equipment
were available to the investigator in the Human Nutrition Laboratory at FIU.
Determination of serum 8OHdG
Several studies report an association of serum 8OHdG levels in subjects afflicted
with different chronic diseases. The literature provides evidence that elevated levels of
serum 8OHdG is associated with poor prognosis in patients with ovarian cancer (Pylvas
et al., 2011), T2D, kidney disease (Kato et al., 2003), and also with obesity (Al-Aubaidy
& Jelinek, 2011). The source of the circulating 8OHdG was not determined in neither of
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these studies nor our study. Kikuchi et al. (2002) reported that elevated level of 8OHdG
was observed in serum but not in cerebrospinal fluid in patients with Parkinson’s disease,
which suggest that 8OHdG may have originated from peripheral tissues.
The reagents used in the measurement of serum 8OHdG were manufactured by
Cayman Chemicals (Ann Arbor, MI; Catalog#589320) and the analytical procedure was
followed precisely according to the manufacturer’s instructions. The micro titer plate
found in this kit utilized an anti-mouse IgG antibody and an 8OHdG enzyme conjugate.
The kits contained all reagents necessary to perform analysis except for a micro titer plate
reader which was available in the Human Nutrition Laboratory at FIU.
The principle of this assay is based on the competition between oxidative
damaged guanine species and an 8OHdG-acetylcholinesterase conjugate (tracer).
Aliquots of standards, controls and specimen were pipetted according to micro titer plate
layout and then the tracer was added. The micro titer plate was incubated for 18 hours at
4 degrees C, after which they were rinsed with a wash buffer and then an Ellman’s
Reagent was added. The plates were incubated for 120 minutes at room temperature and
then the absorbance was measured by a micro titer plate spectrophotometer. The estimate
of the oxidative DNA damage was determined by comparing the absorbance of an
unknown specimen to the standard curve determined by the assay. In this study, the
intra- assay and inter-Assay CV for the 8OHdG assay was calculated to be 6.2%and
4.5%, respectively, which is an acceptable range of variation.
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Determination of serum MnSOD
The scientific literature contains very few studies on the relationship of serum
MnSOD and health related conditions in humans, however we found numerous reports on
the association of MnSOD with diseases in animal models. In human models, Lin et al.
(2005) studied the role of serum MnSOD in patients with gastric cancer and found a
weak, but not significant, association. Tamai et al., 2011) studied the role of serum
MnSOD and hepatocellular carcinoma (HCC) and reported a significantly higher level of
MnSOD in subject with HCC compared with subjects without HCC. Additionally, they
reported that their findings were clinically significant in that serum MnSOD may be used
to predict prognosis in HCC. There were no recent studies publications that dealt with
serum MnSOD with MnSOD in tissue. We found one study where Koshida et al. (1996)
reported positive relationship with testicular tumors with serum MnSOD but not with
tissue MnSOD. The source of circulating MnSOD is not clear (Schandendorf et al.,
1995) and the limited reports suggest that serum MnSOD is a sensitive biomarker for
malignant tumors (Koshida et al., 1996; Ishikawa et al., 1990).
The reagent kits used in this study were manufactured by Young In Frontier Co.,
Ltd (Seoul, Korea; Catalog# LF-EK0104) and the analytical procedure was followed
according to the instructions found in the manufacturer’s package insert. The contents of
the reagent kit included all reagents necessary for the analysis, which included a micro
titer plate that had been pre-coated with a monoclonal antibody specific to human
MnSOD. Prior to the analyses, the samples were thawed and brought to room
temperature. Aliquot of the sample, standards, and controls were pipetted into the precoated micro titer plate and was then incubated at room temperature with constant
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agitation for 2 hours. The wells were then washed. A working antibody solution was
added and then allowed to incubate for 1 hour at room temperature. After incubation, the
wells were washed again and a working AV-HRP solution (conjugate) was added to each
well. Wells were allowed to incubate for an additional 30 minutes at room temperature.
The plate was washed and a substrate solution was added to each well and incubated for
10 minutes. A stop solution was added at the end of incubation period. The micro plate
was then read on a 450nm using a micro plate reader. In this study, the intra- assay and
inter-Assay CV for the MnSOD assay was calculated to be 5.5% and 3.1%, respectively.
Covariates
The covariates in this study were age, gender, smoking status, education, BMI,
energy intakes, ethnicity, and diabetes status. These variables were shown to be strongly
associated with oxidative stress and ROS (Zhu et al., 2012; Whaley-Connell et al., 2012;
Pryor, 1997; Moller et al., 1996). Oxidative stress and reactive oxygen species levels
progressively increase with aging (Andriollo-Sanchez et al., 2005; Junqueira et al., 2004;
Harman, 1956) and may be related to a decline in the body’s primary antioxidant defense
system. There is evidence of gender-related differences in oxidative stress levels and the
literature report lower levels of oxidative stress in female genders than males, suggesting
that the female gender have a reduced susceptibility for DNA damage than males (Hakim
et al., 1012; Vina et al., 2011). Additionally, Hakim et al. reported greater levels of
oxidative stress biomarkers in subjects who smoke compared to non-smokers. Oxidative
stress increases with BMI and age in African Americans (Wonisch et al., 2012; Warolin
et al., 2014) and oxidative stress levels have been found to be higher in African
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Americans than in Whites. (Morris et al. (2012). Oxidative stress has been proposed as
the root cause in T2D and excessive levels of ROS have been in subjects with T2D
(Phillips et al., 2004; Wright et al., 2006).
Statistical Analysis
Data were analyzed using SPSS, Version 20.0 (SPSS Inc., Chicago, IL, U.S.).
Descriptive statistics were used, and the results were expressed either as means ±
standard deviations, or frequencies and percentages. The significance level was set as p <
.05 for all tests. The relationships between the variables were analyzed using analysis of
covariance (ANCOVA), Pearson’s correlations, or multiple linear regression. Since
MnSOD was not normally distributed, the natural logarithm of MnSOD was used in all
analyses. The ANCOVA was used to compare the levels of 8OHdG and MnSOD
between ethnic groups. Pearson’s correlations and multiple linear regressions were used
to determine the associations between dietary antioxidant intake and MnSOD and
8OHdG by ethnicity and as well as their interaction. Full models included all potentially
significant demographics (age, gender, smoking status, energy intake, and education) and
the physical covariate (BMI). Final models included age, gender, and all covariates
which had p-values ≤ .20 for the Pearson correlations with the dependent variables and
diabetes status. Multiple linear regression analysis was used to compare the continuous
dependent variables, i.e., enzymes and mtDNA damage byproduct, with diabetes status
and ethnicity.
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CHAPTER IV
RESULTS
This chapter is organized according to the research questions and into sections
according to the aims of the study. The first section includes the general characteristics
of the study participants by ethnicity and diabetes status. First, socio-demographics are
presented and then oxidative stress markers, and finally glycemic control biomarkers.
The second section contains correlations among socio-demographics and biomarkers.
The tests of the hypotheses are presented in the last section.
Section 1: General Characteristics of Participants
This cross-section study compared African Americans and Haitian Americans by
their ethnicity and diabetes status. There were complete data for 443 participants: 233
with T2D and 210 free of diabetes; 209 African Americans and 235 Haitian Americans.
Table 1 presents the socio-demographics by ethnicity. African American were
significantly younger (M = 53.3 vs. M = 55.6; p < .018), had a higher BMI (kg/m2) (M =
32.8 vs. M = 29.3; p < .001), higher percentage of smokers (34% vs. 6.4%; p < .001), a
higher calculated energy intake (kcal/day) (Md = 1925 vs. Md = 1650; p < .001) and
were more educated (more than high school, 57% vs. 33%; p < .001) as compared to
Haitian Americans.
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Table 1
General Characteristics of Participants by Ethnicity
Ethnicity

Variables

African

Haitian

Americans

Americans

(n = 209)

(n = 234)

53.3 ± 9.5

55.6 ± 10.7

.018

50.2

47.0

.497

32.8 ± 7.1

29.3 ± 4.8

< .001

34.4

6.4

< .001

Age (years)
Gender (male) %
BMI (kg/m2)
Smoke (yes) %
Energy Intake (kcal/day)

1925 (1400)

1650 (1109)

Education (%)

P-value

< .001
< .001

< Grade 8

1.9

31.6

Some high school

13.4

14.5

High school grad/GED

28.2

20.5

Some college/technical school

38.3

17.1

College graduate (bachelor’s degree)

11.0

12.0

7.2

4.3

Graduate degree

Data are median (interquartile range) or means ± SD unless otherwise indicated. BMI =
body mass index.
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Table 2 shows the comparison of the participants by diabetes status. Participants
with T2D were significantly older than participants without diabetes (M = 56.3 vs. M =
52.7; p < .001) and had higher BMI (kg/m2) (M = 32.1 vs. M = 29.7; p < .001).
Participants with T2D did not have lower calculated energy intake (kcal/day) (Md = 1681
vs. Md = 1834; p = .052) than those without T2D, although the difference approached
significance. There were no differences in gender, percentage of smokers, or educational
status for participants with and without T2D.
The participants were also compared by both ethnicity and diabetes status using
two-way ANOVA or non-parametric ANOVA (Table 3). African Americans with T2D
had significantly higher BMI (kg/m2) (M = 34.7) than African Americans without T2D
(M = 30.6) and Haitian Americans with and without T2D (Ms = 29.6, 29.0, respectively).
There were no significant differences for BMI in Haitian Americans with T2D compared
to without T2D. Haitian Americans with T2D had significantly lower energy intake
(kcal/day) (M = 1430) than Haitian Americans without T2D (M = 1719), and both had
significantly lower intakes than African Americans with and without T2D (Mds = 1857,
2020, respectively). Finally, a greater percent of Haitian Americans with T2D had less
than grade 8 educations than those without T2D. Thirty six percent of Haitian Americans
with T2D had less than 8 years education compared with 26.5% of Haitian Americans
without T2D and African Americans with and without T2D (3.6%, 0.0%, respectively).
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Table 2
General Characteristics of Participants by Diabetes Status
Diabetes
Variables
Age (years)

Yes

No

(n = 233)

(n = 210)

56.3 ± 10.3

52.7 ± 9.8

< .001

49.5

47.6

.692

32.1 ± 6.5

29.7 ± 5.7

< .001

18.5

20.6

.591

1834 (1382)

.052

Gender (male) %
BMI (kg/m2)
Smoke (yes) %
Energy Intake (kcal/day)

1681 (1306)

Education (%)

P-value

.072

< Grade 8

14.2

20.6

Some high school

11.4

16.3

High school grad/GED

24.2

24.0

Some college/technical school

28.5

25.7

College graduate (bachelor’s degree)

13.3

9.8

8.1

3.4

Graduate degree

Data are median (interquartile range) or means ± SD unless otherwise indicated. BMI =
body mass index.
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Table 3
General Characteristics of Participants by Ethnicity and Diabetes Status
Ethnicity
Diabetes Status

African Americans

Haitian Americans

Yes

No

Yes

No

Variables

(n = 112)

(n = 97)

(n = 121)

(n = 113)

Age (years)

54.8 ± 10.2b

51.7 ± 8.6a

57.6 ± 10.3b

53.5 ± 10.7a

50.0

50.5

45.5

48.7

34.7 ± 7.1b

30.6 ± 6.4a

29.6 ± 4.8a

29.0 ± 5.0a

35.7 b

33.0 b

1857 (1457)c

2020 (1296)c

Gender (male) %
BMI (kg/m2)
Smoke (yes) %
Energy Intake (kcal/day)

6.6 a

6.2 a

1430 (1150)a

1719 (1210)b

36.4 b

26.5 a

Education (%)
< Grade 8

3.6b

0.0 a

Some high school

14.3

12.4

18.2

10.6

High school grad/GED

28.6

27.8

19.8

21.2

Some college/technical school

38.4

38.1

14.0

20.4

College graduate (bachelor’s degree)

8.9

13.4

10.7

13.3

Graduate degree

6.3

8.2

0.8

8.0

Data are median (interquartile range) or means ± SD unless otherwise indicated. Variables in the four groups with different
superscripts are significantly different using Holm’s sequential Bonferroni post hoc test, p < .05. BMI = body mass index.
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The participants were also compared by both ethnicity and diabetes status using
two-way ANOVA or non-parametric ANOVA (Table 3). African Americans with T2D
had significantly higher BMI (kg/m2) (M = 34.7) than African Americans without T2D
(M = 30.6) and Haitian Americans with and without T2D (Ms = 29.6, 29.0, respectively).
Haitian Americans with T2D had significantly lower energy intake (kcal/day) (Md =
1638) than Haitian Americans without T2D (Md = 1719), and both had significantly
lower intakes than African Americans with and without T2D (Mds = 1857, 2020,
respectively). Finally, there was a greater percent of participants with T2D who had less
than grade eight educations. Thirty six percent of Haitian Americans with T2D had less
than grade 8 education compared with 26.5% of Haitian Americans without T2D. Four
percent of African Americans with T2D had less than grade 8 education compared to
0.0% without T2D.
Biomarkers
Table 4 shows glycemic control and oxidative stress biomarkers of participants by
ethnicity. African Americans had lower A1C levels (%) than Haitian Americans (M =
6.7 vs. M = 7.1; p = .014). African Americans had higher MnSOD levels (pg/ml) (M =
2538 vs. M = 2016), and higher 8OHdG levels (pg/ml) (M = 1691 vs. M = 1626; p =
.003) than Haitian Americans.

49

Table 4
Biomarkers of Glycemic Control and Oxidative Stress of Participants by Ethnicity
Ethnicity

Variables

Fasting plasma glucose (mg/dl)
Hemoglobin A1C (%)
MnSOD (pg/ml)
Ln-MnSOD
8OHdG (pg/ml)

African

Haitian

Americans

Americans

(n = 209)

(n = 234)

121.0 ± 51.2

129.1 ± 56.7

.117

6.7 ± 1.5

7.1 ± 2.1

.014

2538.0 ± 1091.8

2015.8 ± 656.3

< .001

7.7 ± 0.5

7.6 ± 0.3

< .001

1691.0 ± 225.1

1626.2 ± 222.9

P‐value

.003

MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-hydroxy-2”-deoxyguanosine;
Ln-MnSOD = Natural logarithm of Manganese Superoxide Dismutase.
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Biomarkers of glycemic control and oxidative stress of participants were
compared by diabetes status as shown in Table 5. Participants with T2D had higher
fasting plasma glucose (mg/dl) and A1C levels (%), had lower MnSOD levels (pg/dl),
and higher 8OHdG levels (pg/dl) than subjects without T2D.
The participants were also compared by both ethnicity and diabetes status as
shown in Table 6. Haitian Americans with T2D had significantly higher fasting plasma
glucose (mg/dl) (M = 158) than African Americans with T2D (M = 143), and both had
significantly higher fasting plasma glucose than African Americans and Haitian
Americans without T2D (Ms = 96, 99, respectively). Similarly, Haitian Americans with
T2D had significantly higher A1C levels (%) (M = 8.4) than African Americans with
T2D (M = 7.5), and both had significantly higher A1C levels than African Americans and
Haitian Americans without T2D (Ms = 5.9, 6.0, respectively).
African Americans without T2D had the highest MnSOD levels (pg/ml) (M =
3541) of the four groups, Haitian Americans with T2D had the second highest MnSOD
levels (M = 2174), Haitian Americans without T2D had the next highest MnSOD levels
(M = 1846), and African Americans without T2D had the lowest MnSOD levels (M =
1669). These differences were all significant.
The serum levels of 8OHdG (pg/ml) in African Americans with T2D were
significantly higher (M = 1796) than those of the other three groups. Haitian Americans
with T2D had significantly higher levels of 8OHdG (M = 1735) than African Americans
without T2D and Haitian Americans without T2D (Ms = 1570, 1510, respectively).
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Table 5
Biomarkers of Glycemic Control and Oxidative Stress of Participants by Diabetes Status
Diabetes
Yes

No

Variables

Fasting plasma glucose (mg/dl)
Hemoglobin A1C (%)
MnSOD (pg/ml)
Ln-MnSOD
8OHdG (pg/ml)

P-value
(n = 233)

(n = 210)

150.5 ± 63.7

97.4 ± 15.3

< .001

7.9 ± 2.1

5.9 ± 0.4

< .001

1931.6 ± 630.1

2628.9 ± 1054.8

< .001

7.5 ± 0.3

7.8 ± 0.4

< .001

1764.2 ± 188.6

1537.6 ± 203.5

< .001

MnSOD= Manganese Superoxide Dismutase; 8OHdG= 8-hydroxy-2”-deoxyguanosine;
Ln-MnSOD = Natural logarithm of Manganese Superoxide Dismutase.
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Table 6
Biomarkers of Participants by Ethnicity and Diabetes Status
Ethnicity

African Americans

Haitian Americans

Diabetes
Yes

No

Yes

No

(n = 112)

(n = 97)

(n = 121)

(n = 113)

Status
Variables
Fasting plasma glucose (mg/dl)
Hemoglobin A1C (%)
MnSOD (pg/ml)
Ln-MnSOD
8OHdG (pg/ml)

143.0 ± 61.0b

95.8 ± 13.2a

157.6 ± 65.5c

98.7 ± 16.9a

7.5 ± 1.8b

5.9 ± 0.4a

8.4 ± 2.4c

6.0 ± 0.5a

1669.3 ± 521.3d

3541.1 ± 609.4a

2174.4 ± 626.7b

1845.9 ± 647.3c

7.4 ± 0.3a

8.2 ± 0.2d

7.6 ± 0.3c

7.5 ± 0.3b

1795.9 ± 194.7c

1569.9 ± 196.0a

1735.0 ± 178.7b

1509.8 ± 206.5a

Variables in four groups with different superscript are significantly different using Holm’s sequential Bonferroni post hoc test,
p < .05. MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8-hydroxy-2”-deoxyguanosine; Ln-MnSOD = Natural
logarithm of Manganese Superoxide Dismutase.
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Macro and Micronutrients
Table 7 presents the macro and micronutrient intake of participants by ethnicity.
Non-parametric tests were conducted on all variables, since all were non-normally
distributed, so results were reported with median and interquartile range (IQR). African
Americans had significantly higher median calculated energy intake (kcal/day) (1925 vs.
1650; p < .001), protein intake (g/day) (76.6 vs. 62.4; p < .001), fat intake (g/day) (72.4
vs. 45.3; p < .001), vitamin D intake (IU/day) (455.6 vs. 268.7; p < .001), vitamin E
intake (IU/day) (11.0 vs. 7.9; p = .004), and zinc intake (mg/day) (12.6 vs. 9.0; p < .001)
than Haitian Americans. Conversely, Haitian Americans had a significantly higher
median intake of fiber (g/day) (24.1vs.17.0; p < .001) and carotenoids (IU/day) (11864
vs. 5636; p < .001) than African Americans.
Table 8 presents the macro and micronutrients intake of participants by diabetes
status. Subjects with T2D had a significantly lower median carbohydrate intake (g/day)
(225.4 vs. 257.6; p = .012), vitamin E intake (IU/day) (8.1 vs. 10.7; p = .030), and
vitamin C intake (IU/day) (156.0 vs. 201.2; p = .002) than subjects without T2D.
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Table 7
Macro and Micronutrients Intake of Participants by Ethnicity
Ethnicity
African Americans

Haitian Americans

(n = 209)

(n = 234)

1924.8 (1400.0)

1649.9 (1109.0)

< .001

76.6 (54.7)

62.4 (46.4)

< .001

249.0 (192.8)

229.9 (165.0)

Fat intake (g/day)

72.4 (53.4)

45.3 (40.6)

< .001

Fiber intake (g/day)

17.0 (15.8)

24.1 (19.6)

< .001

Vitamin E (IU/day)

11.0 (17.6)

7.9 (10.5)

.004

Vitamin D (IU/day)

455.6 (498.9)

268.7 (384.2)

< .001

Vitamin C (mg/day)

174.1 (221.0)

175.3 (191.6)

.938

Manganese (mg/day)

3.4 (3.1)

4.5 (3.2)

.009

Carotenoids (IU/day)

5635.7 (8240.0)

11864.4 (13762.3)

< .001

12.6 (12.0)

9.0 (7.2)

< .001

P‐value

Variables
Energy Intake (kcal/day)
Protein intake (g/day)
Carbohydrate intake (g/day)

Zinc (mg/day)

Data are expressed as median (interquartile range).
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.107

Table 8
Macro and Micronutrients Intakes of Participants by Diabetes Status
Diabetes
Yes

No

Variables

P-value
(n=233)

(n=210)

1680.7 (1306.0)

1834.1(1382.0)

.052

68.5 (50.0)

69.9 (48.6)

.823

225.4 (173.4)

257.6 (172.3)

.012

Fat intake (g/day)

54.1 (46.8)

57.6 (54.1)

.406

Fiber intake (g/day)

20.3 (17.6)

21.3 (19.2)

.294

Vitamin E (IU/day)

8.1 (11.5)

10.7 (16.5)

.030

Vitamin D (IU/day)

325.8 (431.5)

355.9 (509.1)

.052

Vitamin C (mg/day)

156.0 (181.2)

201.2 (241.7)

.002

Manganese (mg/day)

3.7 (3.1)

3.9 (3.1)

.334

Carotenoids (IU/day)

7153.0 (10132.5)

8435.4 (12374.0)

.214

9.8 (10.0)

10.7 (10.2)

.376

Energy Intake (kcal/day)
Protein intake (g/day)
Carbohydrate intake (g/day)

Zinc (mg/day)

Data are expressed as median (interquartile range).
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Energy intakes of participants by ethnicity and diabetes status
The participants were compared on the macro and micronutrient intake by
ethnicity and diabetes status using non-parametric ANOVA (Table 9). As seen in Table
3, Haitian Americans with T2D had significantly lower energy intake (kcal/day) (Md =
1430) than Haitian Americans without T2D (Md = 1719), and both had significantly
lower intakes than African Americans with and without T2D (Mds = 1857, 2020,
respectively).
Protein, Carbohydrate, and Fat Intakes by ethnicity and diabetes status
Haitian Americans with T2D had a significantly lower median carbohydrate
intake (g/day) (206.3) than Haitian Americans without T2D (253) and African Americans
with and without T2D (236.6, 259.8, respectively).
Vitamin and Mineral Intakes by ethnicity and diabetes status
Haitian Americans with T2D had a significantly lower median vitamin E intake
(IU/day) (7.3) than the other three groups. In addition, Haitian Americans without T2D
(9.5) and African Americans with T2D (10.4) had significantly lower median vitamin E
intakes than African Americans without T2D (12.3).
Haitian Americans with T2D had a significantly lower median vitamin D intake
(IU/day) (236.4) than the other three groups. Haitian Americans without T2D had a
significantly lower median vitamin D intake (280.5) than African Americans with and
without T2D (371.8, 471.7, respectively).
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Haitian Americans with T2D had a significantly lower median vitamin C intake
(mg/day) (138.4) than Haitian Americans without T2D (203.9) and African Americans
with and without T2D (165.6 and 198.1, respectively).
Haitian Americans without T2D had a higher median manganese intake (mg/day)
(4.4) than the other three groups. Median intakes for Haitian Americans with T2D was
4.1 mg/day, for African American without T2D (3.4), and for African Americans with
T2D (3.3).

58

Table 9
Macro and Micronutrients Intake of Participants by Ethnicity and Diabetes Status
Ethnicity
Diabetic Status

African Americans

Haitian Americans

Yes

No

Yes

No

(n = 112)

(n = 97)

(n = 121

(n = 113)

Energy Intake (kcal/day)

1857 (1457)c

2020 (1296)c

1430 (1150)a

1719 ( 1210)b

Protein intake (g/day)

75.9 (58.6)b

79.4 (56.4)b

60.1 (51.8)a

63.5 (42.9)a

236.6 (210.0)b

259.8 (171.6)b

206.3 (145.8)a

253.4 (174.5)b

Fat intake (g/day)

70.0 (58.0)b

73.5 (49.5)b

41.9 (41.4)a

46.4 (41.2)a

Fiber intake (g/day)

16.6 (13.6)a

18.3 (17.1)a

22.4 (18.8)b

25.2 (21.1)b

Vitamin E (IU/day)

10.4 (15.7)b

12.3 (19.4)c

7.3 (8.8)a

9.5 (11.4)b

Vitamin D (IU/day)

371.8 (472.7)c

471.7 (569.9)c

236.4 (380.3)a

280.5 (425.5)b

Vitamin C (mg/day)

165.6 (208.3)b

198.1 (260.3)b

138.4 (170.0)a

203.9 (237.2)b

Manganese (mg/day)

3.3 (3.1)a

3.4 (3.4)a

4.1 (3.2)a

4.4 (2.9)b

Carotenoids (IU/day)

5618.8 (7236.7)a

5644.1 (9472.6)a

11368.3
(13612.3)b

12162.4
(14915.2)b

12.2 (12.2)b

13.0 (11.9)b

9.0 (7.8)a

9.0 (6.8)a

Variables

Carbohydrate intake (g/day)

Zinc (mg/day)

Data are expressed as median (interquartile range). Variables in groups with different superscripts are significantly different
using Holm’s sequential Bonferroni post hoc test, p < .05.
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Section 2: Correlations
Correlation of Oxidative Stress Biomarkers and Socio-demographic
Characteristics
This section contains results of the correlation analysis between
biomarkers and socio-demographics using Pearson’s and point bi-serial
correlations, depending on the type of socio-demographic variable. The
associations between Ln-MnSOD and 8OHdG levels and dietary antioxidant
intakes were analyzed with Pearson’s correlations. Additionally, Pearson’s and
point bi-serial correlations measured the relationship between glycemic control
with socio-demographic variables and dietary antioxidant intakes for study
participants with T2D. Overall, there was a significant negative correlation
between Ln-MnSOD and 8OHdG, r = - .17, p < .001, so that lower levels of LnMnSOD associated with higher levels of 8OHdG.
Correlation of Oxidative Stress Biomarkers and Study Variables
Table 10 presents the Pearson’s correlation analysis of oxidative stress
biomarkers with study variables. Ln-MnSOD was negatively correlated with
BMI, r = - .15, p < .05, and 8OHdG was positively correlated with BMI, r = .15, p < .05, age, r = .13, p < .01, and being male, r = .11, p < .05. Thus, lower
levels of Ln-MnSOD were associated with greater BMI, while higher levels of
8OHdG were associated with greater BMI, being older and being male.
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Table 10
Pearson’s Correlations of Oxidative Stress Biomarkers with Study Variables
Participants (n = 433)
Variables

MnSOD

Age (years)
Gender (male)

Ln-MnSOD

8OHdG

-.10*

-.09

.13**

.07

.06

.11*

BMI (kg/m2)

-.15**

Smoke (yes)

.10*

.07

.04

Energy Intake(kcal/day)

.04

.02

-.05

Education

.08

.07

.01

Less than high school

-.11*

-.10*

-.03

High school grad/GED

.07

.07

.04

Some college/technical school

.07

.06

-.01

-.02

-.02

.00

Graduate school

-.15**

.15**

* p < .05, ** p < .01
BMI = body mass index; MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8hydroxy-2”-deoxyguanosine. Ln-MnSOD = Natural logarithm of Manganese
Superoxide Dismutase.
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Table 11 presents Pearson’s correlation analysis of oxidative stress
biomarkers with dietary antioxidants intakes. Lower levels of Ln-MnSOD were
associated with lower levels of zinc, r = .10, p < .05, and higher levels of
carotenoids, r = -.10, p < .05. Higher levels of 8OHdG were associated with
lower levels of Vitamin D, r = -.14, p < .01, and carotenoids, r = -.09, p < .05.
Table 12 presents Pearson’s correlation analysis of glycemic control with
socio-demographic variables and dietary antioxidant intakes for study
participants with T2D. Diabetic participants with higher FPG had lower intakes
of Vitamin D, r = -.14, p < .05. Higher A1C levels in T2D participants were
associated with being Haitian, r = -.19, p < .01, and having less education, r = .14, p < .05.
In addition, for Haitian Americans with T2D, higher FPG levels were
associated with lower BMI, r = -.25, p < .01, and lower Vitamin C intakes, r = .19, p < .05. For African Americans with T2D, higher FPG levels were
associated with higher Vitamin E intakes, r = -.25, p < .01. Higher A1C levels
were associated with lower carotenoids intakes, r = -.19, p < .05, for this group.
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Table 11
Pearson’s Correlations of Oxidative Stress Biomarkers with Study Variables
Participants (n = 433)
Variables

MnSOD

LnMnSOD

8OHdG

.04

.02

-.05

Vitamin E / 1000 kcal/day

-.00

-.01

.01

Vitamin D / 1000 kcal/day

.08

.07

-.02

Vitamin C / 1000 kcal/day

.06

.07

-.14**

Manganese / 1000 kcal/day

-.06

-.03

.00

Carotenoids / 1000 kcal/day

-.11*

-.10*

-.09*

Zinc / 1000 kcal/day

.10*

.10*

.00

Energy Intake (kcal/day)

* p < .05, ** p < .01
BMI = body mass index; MnSOD = Manganese Superoxide Dismutase; 8OHdG = 8hydroxy-2”-deoxyguanosine. Ln-MnSOD = Natural logarithm of Manganese
Superoxide Dismutase.

63

Table 12
Pearson’s Correlations of Glycemic Control with Study Variables in Individuals with
T2D
Glycemic Control
(n = 433)
Variables

FPG

A1C

Ethnicity (African American)

-.12

-.19**

Age (years)

-.04

-.10

Gender (male)

.07

.06

BMI (kg/m2)

-.12

-.07

Smoke (yes)

-.04

.01

Energy Intake(kcal/day)

-.06

-.09

Education

-.10

-.14*

Less than high school

.09

.13

high school grad/GED

-.01

-.04

some college/technical school

-.03

-.04

graduate school

-.08

-.08

Vitamin E / 1000 kcal

.11

-.01

Vitamin D / 1000 kcal

-.14*

-.02

Vitamin C / 1000 kcal

-.07

-.05

Manganese / 1000 kcal

.01

.04

Carotenoids / 1000 kcal

.04

.02

-.04

-.05

Zinc/1000 kcal

* p < .05, ** p < .01
A1C = glycosylated hemoglobin; FPG = fasting plasma glucose; BMI = body mass
index.
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Section 3: Hypotheses Testing

Hypothesis testing was conducted with Analysis of Covariance
(ANCOVA), and multiple linear regression analysis. We compared the levels of
MnSOD and 8OHdG by ethnicity and diabetes status using ANCOVAs. Post
hoc test using Fisher’s LSD procedure were carried out on the adjusted ethnic
and diabetes status means for significant tests of interaction.
Relationships of MnSOD and 8OHdG with dietary antioxidants by
ethnicity and diabetes status were analyzed by multiple linear regression
analyses. The relationships between glycemic controls (A1C) and fasting plasma
glucose levels (FPG) with dietary antioxidants by ethnicity and diabetes status
were determined with multiple linear regression analyses. The covariates for all
analyses were age, gender, smoking status, education, BMI, and energy intake.
Aim 1. To determine the differences in serum MnSOD and 8OHdG by
diabetes status and ethnicity.

Hypothesis 1a: Serum levels of MnSOD will be lower in participants with
T2D as compared to those without T2D, independent of ethnicity

ANCOVA on Manganese Superoxide Dismutase (MnSOD)
In a two way ANCOVA on Ln-MnSOD by ethnicity (Haitian, African
American) and diabetes status (yes/no), both main effects were significant,
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ethnicity, F(1,433) = 55.46, p < .001, ƞ2 = .11, diabetes status, F(1,433) =
108.57, p < .001, ƞ2 = .20. However, the main effects were moderated by
significant interaction of ethnicity by diabetes status, F(1,433) = 293.43, p <
.001, ƞ2 = .40. By convention, a “small” effect is ƞ 2 = .01, a “medium” effect is
ƞ 2 = .06, and a “large” effect is ƞ 2 = .16. These effects were all very large. The
adjusted mean Ln-MnSOD for African Americans without diabetes (M = 8.16)
was significantly larger than for African Americans with diabetes (M = 7.40) and
for Haitian Americans with and without diabetes (M = 7.63; M = 7.46,
respectively).
Hypothesis one was not supported. Although African Americans with
diabetes had lower MnSOD levels than African Americans without diabetes, this
was not the case for Haitian Americans, so lower serum levels of MnSOD in
T2D participants was not independent of ethnicity.
Hypothesis 1b: Serum levels of 8OHdG will be higher in participants with
T2D when compared to without T2D, independent of ethnicity.

ANCOVA on mtDNA 8-hydroxy-2’-deoxyguanosine (8OHdG)
In a two way ANCOVA on 8OHdG by ethnicity and diabetes status, both
main effects were significant, ethnicity, F(1, 433) = 6.44, p = .012, ƞ2 = .02,
diabetes status F(1,433) =126.38, p < .001, ƞ 2 = .23. There was not a significant
interaction effect, F(1,433) = .05, p = .826, ƞ 2 < = .01.
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In support of Hypothesis 1b, the adjusted 8OHdG mean (M = 1761.36)
for individuals with diabetes was significantly higher than those without diabetes
(M = 1544.11), independent of ethnicity. Additionally, the adjusted 8OHdG
mean for African Americans (M = 1680.47) was significantly higher than for
Haitian Americans (M =1625.00).
Hypothesis 1c: There will be an inverse relationship between serum levels
of MnSOD and 8OHdG in participants with T2D, independent of ethnicity.

Multiple Linear Regression of MnSOD with 8OHdG
The multiple regression analysis of 8OHdG on MnSOD with control
variables of ethnicity, diabetes status, age, gender, smoking status, education,
BMI, and energy intake was significant, R2 = 29.6%, F(10,433) = 18.15, p <
.001. However, MnSOD did not explain significant additional variability of
8OHdG, R2 change = 0.3%, F(1,432) = 2.14, β = -.09, p = .145. In the final
model, significant covariates were: having T2D, β = .51, p < .001, being male, β
= .14, p = .002, and being African American, β = .22, p = .011.
Hypothesis 1c was not supported in that the data did not show an inverse
relationship between the serum levels of MnSOD and 8OHdG in African
Americans and Haitian Americans with T2D.
Aim 2: To determine the relationships of serum MnSOD and 8OHdG with
various dietary antioxidants by diabetes status and ethnicity.
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Hypothesis 2a: Serum 8OHdG levels will be negatively associated with
dietary intake of antioxidants, independent of diabetes status and ethnicity.

Multiple Linear Regression of 8OHdG on dietary intake of antioxidants
Multiple linear regression analysis showed that vitamin C intake per 1000
kcal explained significant additional variability of 8OHdG, R2 change = 0.8%,
F(1,432) = 5.25, β = - .10, p = .022. In this model, lower levels of 8OHdG were
associated with higher vitamin C levels after controlling for age, gender,
smoking status, education, BMI, energy intake, ethnicity, diabetes status and the
interaction between ethnicity and diabetes status. Significant covariates were:
having type 2 diabetes, β = .48, p < .001; being African American, β = .13, p =
.034; the interaction between having type 2 diabetes and African American, β = .14, p < .001; and being male, β = .12, p < .005.
Vitamin D intake per 1000 kcal did not explain significant additional
variability of 8OHdG, R2 change = 0.0%, F(1,432) = 0.10, β = .01, p = .922.
Significant covariates were: having type 2 diabetes, β = .49, p < .001; being
male, β = .13, p = .002; and being African American, β = .13, p = .037.
Vitamin E intake per 1000 kcal did not explain significant additional
variability of 8OHdG, R2 change = 0.0%, F(1,432) = 0.80, β = .01, p = .927.
Significant covariates were: having type 2 diabetes, β = .49, p < .001; being
male, β = .13, p = .003; and being African American, β = .13, p = .035.
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Carotenoids intake per 1000 kcal did not explain significant variability of
8OHdG, R2 change = 0.2%, F(1,432) = .975, β = - .04, p = .324. Significant
covariates were: having type 2 diabetes, β = .49, p < .001; and being male, β =
.13, p = .003.
Hypothesis 2a was supported for vitamin C, but not for vitamin D, E, or
carotenoids.
Hypothesis 2b: MnSOD levels will be negatively associated with dietary
intake of antioxidants, independent of diabetes status and ethnicity.

Multiple linear regression analysis on MnSOD on dietary intake of
antioxidants
Vitamin C intake per 1000 kcal did not explain significant additional
variability of ln-MnSOD, R2 change = 0.2%, F(1, 432)= 1.90, p = .169.
Significant covariates were being African American, β = .878, p < .001, having
diabetes, β = .22, p <.001, and interaction between ethnicity and diabetes status,
β= -1.01, p < .001.
Vitamin D intake per 1000 kcal did not explain significant additional
variability of ln-MnSOD, R2 change = 0.0%, F(1, 432)= .294, p = .588.
Significant covariates were being African American, β = .872, p < .001, having
diabetes, β = .215, p < .001, and interaction between ethnicity and diabetes status
β = -1.007, p < .001.
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Vitamin E intake per 1000 kcal did not explain significant additional
variability of ln-MnSOD, R2 change = 0.1%, F(1,432) = .879, p = 0.349.
Significant covariates were being African American, β = .88, p < .001, having
diabetes, β = .21, p < .001, and the interaction between African American and
diabetes status, β = -1.01, p < .001.
Carotenoids intake per 1000 kcal did not explain significant additional
variability of ln-MnSOD, R2 change = 0.1%, F(1, 432)= 1.268, p = .261.
Significant covariates were being African American, β = .863, p < .001, having
diabetes, β = .215, p < .001, and interaction between ethnicity and diabetes
status, β = -1.009, p < .001.
Hypothesis 2b was not supported for any of the antioxidants, vitamin C,
D, E or carotenoids.
Aim 3: To examine the relationships of glycemic control (A1C) and fasting
plasma glucose level with dietary antioxidants in T2D by ethnicity.
Control variables for the multiple regression analyses were: ethnicity,
age, gender, education, energy intake, BMI, and smoking status. Only diabetic
participants were included in these analyses.
Haitian Americans with T2D had significantly higher fasting plasma
glucose (mg/dl) (M = 158) than African Americans with T2D (M = 143), and
similarly, Haitian Americans with T2D had significantly higher A1C levels (%)
(M = 8.4) than African Americans with T2D (M = 7.5), (Table 6).
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Hypothesis 3a: There will be no relationship between serum A1C and any
dietary antioxidants in participants with T2D independent of ethnicity.

Multiple Linear Regression of Hemoglobin A1C (A1C)
Vitamin C intake per 1000 kcal did not explain significant additional
variability of A1C, R2 change = 0.0%, F(1,432) = .27,  = .04, p = .601. The
significant covariates was being African American, β = -.19, p = .023.
The multiple regression analysis of A1C on vitamin D was not
significant, R2 = 6.9%, F(8, 224) = 2.09, p = .995. Vitamin D did not explain
significant additional variability in the model, R2 change = 0.0%, β = -.01, p =
.905. The significant covariate was being African American, β = -.20, p = .020.
The multiple regression analysis of A1C on vitamin E, was not
significant, R2 = 6.9%, F(8, 224) = 2.09, p = .943. Vitamin E did not explain
significant additional variability in the model, R2 change = 0.0%, β = .01, p =
.943. The significant covariate was being African American, β = - .20, p = .020.
The multiple regression analysis of A1C on carotenoids, was not
significant, R2 = 6.9%, F(8, 224) = 2.09, p = .685. Carotenoids did not explain
significant additional variability in the model, R2 change = 0.0%, β = .04, p =
.604. The significant covariate was being African American, β = - .12, p = .045.
Hypothesis 3a was supported since A1C was not related to any of the
antioxidants, vitamin C, D, E or carotenoids, for T2D participants.
71

Hypothesis 3b: There will be no relationship between fasting plasma glucose
level and any of the dietary antioxidant intakes in T2D independent of
ethnicity.

Multiple regression analysis of fasting plasma glucose (FPG)
The multiple regression analysis of FPG on vitamin C per 1000 kcal was not
significant, R2 = 4.1%, F(8,224) = 1.20, p = .302. Vitamin C intake did not
explain significant additional variability of FPG, R2 change = 0.1%, F(1,432) =
1.17, β = -.07, p = .280. The significant covariate was being African American,
β = -.19, p = .023.
The multiple regression analysis of FPG on vitamin D per 1000 kcal was not
significant, R2 = 5.3%, F(8,224) = 1.57, p = .135. Vitamin D intake per 1000 kcal
explained significant additional variability of FPG, R2 change = 1.7%, F(1,432)
= 4.05 , β = -.13, p = .045. The significant covariate was being African
American, β = - .20, p = .020.
The multiple regression analysis of FPG on vitamin E intake per 1000 kcal
was not significant, R2 = 4.9%, F(8,224) = 1.44, p = .183. Vitamin E intake did
not explain significant additional variability of FPG, R2 change = 1.3%,
F(1,432) = 3.11 , β = .11, p = .084. The significant covariate was being African
American, β = -.19, p = .023.
The multiple regression analysis of FPG on carotenoids intake per 1000 kcal
was not significant, R2 = 3.7%, F(8,224) = 1.07, p = .388. Carotenoids did not
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explained significant additional variability of FPG, R2 change = 1.9%, F(1,432)
= 2.09 , β = -.14, p = .083.
Hypothesis 3b was supported since fasting plasma glucose was not
significantly related to any of the antioxidants, vitamins C, D, E, or carotenoids
for T2D participants.
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Table 13
Results of Hypothesis Testing
HYPOTHESIS

RESULTS

H1a: Serum levels of MnSOD will be lower

Hypothesis 1a was not supported.
Although African Americans with
diabetes had lower MnSOD levels
than African Americans without
diabetes, this was not the case for
Haitian Americans, so lower serum
levels of MnSOD in T2D participants
was not independent of ethnicity.

in participants with T2D as compared to those
without T2D, independent of ethnicity.

H1b: Serum levels of 8OHdG will be higher
in participants with T2D when compared to those
without T2D, independent of ethnicity.

H1c: There will be an inverse relationship

Hypothesis 1b was supported since
the adjusted serum levels of 8OHdG
mean for individuals with diabetes
was significantly higher than for those
without diabetes, independent of
ethnicity. Also, adjusted 8OHdG
mean for African Americans was
significantly higher than for Haitian
Americans.
Hypothesis 1c was not supported by
the findings in this study.

between serum levels of MnSOD and 8OHdG
in participants with T2D, independent of ethnicity.

H2a: Serum 8OHdG levels will be

Hypothesis 2a was not supported for
vitamin C since multiple linear
regression analysis showed that
vitamin C intake per 1000 kcal
explained significant additional
variability of 8OHdG, R2 change =
0.8%, β = -0.10, p = .022

negatively associated with dietary intake of
antioxidants, independent of diabetes status
and ethnicity.

H2b: Serum MnSOD levels will be negatively

Hypothesis 2b was not supported

since multiple regression analysis
showed that none of the
antioxidants, vitamins C, D, E or

associated with dietary intake of antioxidants,
independent of diabetes status and ethnicity.
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carotenoids, were significant in
explaining the variability of LnMnSOD.

H3a: There will be no relationship between
serum A1C and dietary antioxidants in
participants with T2D independent of ethnicity.

H3b: There will be no relationship between

Hypothesis 3a was supported since
serum A1C was not related to any
of the antioxidants in the multiple
regression analyses on T2D
participants.
Hypothesis 3b was supported
since fasting plasma glucose was
not related to any of the
antioxidants in the multiple
regression analyses on T2D
participants.

fasting serum glucose level and any of the
dietary antioxidant intakes in T2D independent
of ethnicity.
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CHAPTER V
DISCUSSION
This chapter presents the discussion of the results. It is organized as
follows: First, the descriptive statistics of the participants’ general
characteristics and socio-demographic status; Secondly the interpretation and
qualitative analysis are discussed in the order which the aims and hypothesis
were presented in this study. Finally, the study strengths and limitations,
conclusions, and recommendations for future studies are provided.
Researchers and healthcare practitioners recognize that there are ethnic
differences and disparities in many health disorders. It has been reported that
blacks have a higher incidence of diabetes and diabetes related complications
(Huffman et al., 2013) than whites, and there is an increasing awareness of ethnic
group differences among subgroups normally grouped together as blacks. Two
such subgroups are African Americans and Haitian Americans, both of whom
were examined in this research study.
General Characteristics of Participants
African Americans are affected by diabetes disproportionately as
compared to the general population. They are 1.8 times more likely to have
diabetes and also more likely to develop diabetes complications such as kidney
disease, blindness and cardiovascular disease when compared with whites (ADA,
2013). The prevalence of having diabetes in African Americans was determined
to be 18.7 percent (ADA, 2013). Often time poor dietary patterns correlate with
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poor health, and the traditional diet of African Americans called “soul food” has
been reported as being a poor diet, consisting of southern style foods which
include pork chops and fried fatty foods (Anderson-Loftin et al., 2005).
The culture of Haitian Americans may explain the differences in study
variables when compared with African Americans (“Background on Haiti”,
2010). Haitian Americans resistance to healthcare screening may relate to their
mistrust of healthcare providers. This under-utilization of health care resources
may result in undiagnosed or untreated cardiovascular disease and T2D.
According to a report by Huffman et al. (2013), although the diet of Haitian
Americans is healthier than African Americans, it is not necessarily a healthy
diet. The researchers reported that African American diet consisted of high fat
content as compared with Haitian Americans whose diet consisted of fish,
chicken, fruits and vegetables. African Americans scored lower than Haitian
Americans using the Health Eating Index, indicating that Haitian Americans had
a healthier diet than African Americans. The components of a high fat diet
include hydrogenated oils, animal fats, free fatty acids, which are found in
African Americans and may contribute to an increase risk of T2D and this type
of dietary pattern may lead to increased oxidative stress (Watters, et al., 2007).
The information on the general characteristics of the respective diets for
the study participants were obtained from a FFQ completed by the participants
and from physiologic biometrics recorded by trained research assistants. In this
study, African American participants were generally younger, had higher BMI,
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higher energy intakes, were more educated, and had a greater percentage of
smokers than Haitian Americans (Table 1). There were similar numbers of male
and female participants for both ethnicities. The data obtained from the FFQ
show higher energy intakes observed in African Americans which explains the
higher BMI compared with Haitian Americans.
The characteristics of participants by diabetes status are shown in Table
2. Participants with T2D had higher BMI (32.1 kg/m2 ± 6.5) compared with
participants without T2D (29.7 kg/m2 ± 5.7). The average BMI of participants
without T2D were within the range classified as overweight and those with T2D
were classified as obese. Since the participants without T2D were classified as
overweight, they also have an increased risk for diabetes (Sanada et al., 2012).
These findings complement those reported by other researchers (Wee et al.,
2008) who used data obtained from the 1999-2004 National Health and Nutrition
Examination Survey (NHANES).
The participants with T2D had lower energy intake when compared to
participants without T2D. The lower energy intake in participants with T2D may
be explained by low calorie diets which are normally prescribed by healthcare
practitioner as part of a treatment program. It is well documented that there is a
strong positive association between energy intake with insulin resistance (Donin
et al., 2013) and that weight loss is central to glycemic control improvement
(Looker et al., 2001). Additionally, the low energy intake may be a result of
under-reporting or due to false perception of food portion sizes and
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misrepresentation of actual intake (Samuel-Hodge et al. 2004). Olendzki et al.
(2014) reported similar findings about under-reporting and they observed that the
prevalence of under-reporting in a Caribbean Latino population studied was
related to BMI, gender, and educational level. In this study, if the total energy
intake calculated from the FFQ was <500 kcal per day or >5000 kcal per day,
then the data was not included in the analysis. Similar cutoffs were reported by
Hebert et al. (2002) as a common means to exclude reporting errors and extreme
values.
Biomarkers
There are many assays developed to quantify oxidative stress, including
the measure of oxidation of proteins, lipids, DNA, and antioxidant enzymes. The
focus of this study is blood antioxidant enzyme manganese superoxide dismutase
(MnSOD) and the byproduct of mtDNA damage known as 8-hydroxy-2’deguanosine (8OHdG). These variables were studied because of their
localization and interaction in the mitochondria, and also because of their
participation in the T2D associated progressive disorders (Kirk at al., 2006;
Feairheller et al., 2011). The relationship between oxidative stress and diabetes
status was examined because the literature review has shown that reactive
oxygen species also influences the glycemic control (Kirk at al., 2006;
Feairheller et al., 2011). In addition to elevated reactive oxygen species, the
literature presented evidence that there is a direct correlation with elevated levels
of oxidative stress biomarkers.
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Glycemic control can be determined with the blood biomarkers FPG and
A1C (ADA, 2013). This study examined serum levels of oxidative stress
biomarkers and glycemic control indicators and provided data on macro and
micronutrients intakes obtained from food frequency questionnaire. The
relationship of serum levels of manganese superoxide dismutase and mtDNA 8hydroxy-2’-deoxyguanosine were examined. In addition, the relationship when
compared with dietary antioxidants intake in T2D in African Americans and
Haitian Americans, two different ethnic groups, were determined.
An intensive literature search showed limited amount of data on the
differences within minority groups. This study provided information of
differences on serum levels of MnSOD and 8OHdG among African Americans
and Haitian Americans. In addition, this report is the first cross sectional study
that examined the relationship of oxidative stress biomarkers among African
Americans and Haitians with and without T2D.
The aim of this study was to examine the serum levels of 8OHdG, the
surrogate biochemical marker for mtDNA damage, and MnSOD which is the
body’s primary antioxidant enzyme that protects the DNA in the mitochondria.
We also investigated their relationship to dietary antioxidant intakes and
glycemic control. Previous studies (Arab at al., 2011; Kirk at al., 2006;
Feairheller et al., 2011) reported differences between African Americans and
whites for glycemic control, oxidative stress biomarkers, and dietary
antioxidants.

Kirk et al. found ethnic disparities in glycemic control in African
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Americans and Non-Hispanic White adults with diabetes and reported that the
cause of disparity may be related to the access to medical care and the amount of
dietary antioxidants consumed. In this study, differences were found in glycemic
control and dietary antioxidants intakes between African Americans and Haitian
Americans. While access to medical care and attendance of doctor’s visits was
not a part of this project, these variables may have played a role. The findings of
this study show significantly higher levels of 8OHdG and lower levels of
MnSOD found in African Americans with T2D than in Haitian Americans with
T2D, indicating higher oxidative stress among African Americans.
The mitochondria produce superoxide ions, the most abundant ROS
produced, that may participate in the damage of cellular macromolecules. There
is evidence that superoxide has an association with the development of diabetes
complications and that MnSOD is the first line of defense in neutralizing
superoxide in the mitochondria (Du et al., 2003; Brownlee, 2005). This study
showed that the serum levels of MnSOD were higher in African Americans than
Haitian Americans. Upon closer examination, the serum MnSOD levels of
African Americans were lower for those with diabetes compared to without
diabetes. These finding supported previous reports of decreased MnSOD
activity in white blood cells of participants with diabetes compared to those
without diabetes (Wegner, et al., 2014; Kazi et al., 2008). These findings may
be interpreted that the mtDNA is not being protected efficiently due to the reduce
MnSOD level and could lead to development diseases associated with T2D.
Additionally, it was observed that dietary manganese intake level was lower in
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African Americans compared with Haitian Americans, and since manganese is a
cofactor for the production of MnSOD, then may indicate a need for an improved
quality in their diet. Currently there is no information available in the literature
on serum levels of MnSOD in African American versus Haitian Americans.
The significant differences in serum levels of MnSOD and 8OHdG
among African Americans and Haitian Americans provide evidence of ethnic
difference within the black population. African Americans group had greater
levels of both MnSOD and 8OHdG when compared with Haitian Americans.
These observations also suggest that there appears to be ethnic differences in
T2D, a major risk factor for CVD, therefore therapeutic interventions need to be
managed according to ethnicity. To the best of our knowledge, this is the first
time that these differences were determined.
The method that is used to quantify the serum levels of 8OHdG in this
study was based on the ELISA principle, and has been validated and critically
reviewed by Helliwell et al. (1996). The ELISA method is believed to be
advantageous over analytical methods such as HPLC and gas
chromatography/mass spectrometry. This is due to the elimination of artificial
8OHdG which may be introduced during the isolation of DNA, especially in
phenol-based DNA purification procedures (Claycamp, 1992). The fact that we
were able to identify significant association between 8OHdG and MnSOD
suggest that cross-reactivity was not likely to interfere with the validity of the
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assay. In addition, the intra-assay coefficient of variation, 8.5%, indicates that
the ELISA assay had repeatability.
A two way ANOVA showed that ethnicity and diabetes status had a
significant relationship with 8OHdG. Higher levels of serum 8OHdG were
found in T2D group compared to those participants without T2D. In addition,
lower serum 8OHdG levels were found in Haitian Americans with T2D
compared with African Americans with T2D. The role of MnSOD is to protect
mtDNA from oxidative stress, and the data showed that MnSOD was higher
while 8OHdG was lower in Haitian Americans than in African Americans. The
strength of this observation was considered to be large since the effect size was
large for both main effects. These findings indicate that there was more mtDNA
damage in the T2D groups, of which African Americans may have a greater risk
of T2D associated complications when compared with Haitian Americans with
T2D.
The positive correlation of 8OHdG and BMI in the diabetic group
suggests that obesity may have an additive effect with increased fasting plasma
glucose in oxidative mtDNA damage. The covariates were age, gender, smoking
status, education, BMI, and energy intake. Similar results were reported by AlAubaidy et al. (2011) in their clinical study on oxidative DNA damage and
obesity in T2D mellitus. They also suggested that serum 8OHdG levels were
already increasing in prediabetes.
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One of the risk factors for diabetes is smoking, which may contribute to
elevated levels of ROS. Isik et al. 2007 showed that smoking may contribute to
ROS through the weakening of the primary antioxidant defense system and
production of free radicals. The literature provides conflicting evidence of the
relationship of 8OHdG in smokers and non-smokers. In this study, we did not
find any significant correlation of either 8OHdG or MnSOD with smoking, but
this may be attributed to the low sample size of participants who were identified
as smokers, thus the comparison may have lacked the power to detect a
significant difference.
There were significant differences found with 8OHdG and gender.
Gender, in addition to smoking and BMI, was also reported in the literature as
significant predictor of increased 8OHdG levels (Loft, et al., 1992).
Although there was a weak relationship in the overall correlation between
Ln-MnSOD and 8OHdG, there is evidence that higher serum 8OHdG levels were
associated with lower serum MnSOD levels. The regression analysis of 8OHdG
on MnSOD was significant, with covariates of ethnicities, diabetes status, age,
gender, education, energy intake, BMI, and smoking status. However, after
controlling for all covariates, MnSOD did not explain the significance and
additional variability of 8OHdG. In the final model, significant covariates were
being male, African American, and having with T2D.
We examined the relationship between dietary antioxidants intakes and
found that serum 8OHdG levels negatively correlated with vitamin C intakes.
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That is, lower dietary intake of vitamin C was found to be associated with higher
levels of 8OHdG. Similar results were reported by Moller et al. (2002) in a
dietary antioxidant intervention study. This observation may be due to the
possible protection of the mtDNA from oxidative stress. Also, we observed a
negative correlation between dietary carotenoids intakes with MnSOD and
8OHdG. There were no relationship observed between vitamin E and vitamin D
with either MnSOD or 8OHdG.
In T2D, uncontrolled blood glucose levels may participate in disease
pathophysiology which is associated with DNA damage. In this study, the
findings were similar to the studies reported by Salem et al. (2012) in that
subjects with T2D had greater DNA damage, higher levels of inflammation and
oxidative stress, and were positively associated with higher levels of blood
glucose levels. Since high blood glucose levels may interfere with cell
replication and adversely influence the death rate of cells, there is a need to study
ways in which to maintain DNA integrity and also to reduce the abnormal levels
of ROS.
This study used A1C and FPG as indices glycemic control. The data
showed that there were ethnic differences in A1C where African Americans had
lower A1C than Haitian Americans. These findings were similar to Vimalananda
et al. (2011) study that compared diabetes control among Haitians, African
Americans, and Non-Hispanic Whites. Although Haitian Americans appear to
consume less carbohydrate than the African Americans, the Haitian Americans
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had worse glycemic control. These findings may suggest that MnSOD may
contribute to glycemic control, but proper medication use may be a major factor
and this study was not designed to address this variable. Although findings of a
negative relationship with glycemic control and serum MnSOD levels were not
found in the scientific literature for Haitian Americans, a similar relationship was
observed in Type 1 diabetes patients by Wegner et al. (2014). The report did not
identify the ethnicity of the type 1 diabetes patients.
There was a marginal association of fasting plasma glucose with vitamin
E, and vitamin D. Vitamin E intakes were not significant with FPG, but it
explained some variance and it was marginally significant. In addition, dietary
intake of vitamin D was found to be associated with lower fasting plasma
glucose. Dietary intakes of vitamin D were not significantly associated with
FPG, but it explained a small but significant variance in FPG. Saedisomeolia et
al. (2013) had different findings in their cross-sectional study. They observed a
positive relationship between serum vitamin D levels with glycemic control in
Iranians, where 82% of the participants with T2D and 75% of the participants
without T2D were either vitamin D deficient or insufficient. The researchers
interpreted these findings that vitamin D had beneficial effect on glycemic
control.
Strengths of the Study
This study is the first to report on the serum levels of MnSOD and
8OHdG in Haitian Americans with and without T2D, and it also provided data
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on the relationship between these oxidative stress biomarkers with dietary and
glycemic control indicators. This study provides evidence that there are ethnic
difference in African American and Haitian American in dietary intakes,
glycemic control indicators and oxidative stress levels components. This implies
that educators and clinicians should be cognizant that treatment modalities
should be ethnically based.
The instruments used in this study for data collection from the subjects
were validated and standardized. The research personnel were trained to
properly and accurately use the instruments and also correctly complete and
score the questionnaires used to gather information from the participants.
The participants of this study were provided a copy of the results of their
cardiovascular risk analysis, blood glucose levels, A1C, and lipid profile as
determined from the blood collected and, in some cases, they were alerted to
cardiovascular risk that they were not aware or would have identified if it was
not for this study.
Limitations of the Study
A limitation of this study was that it was cross-sectional design and
provided a snapshot relationship. In addition, although a validated nutrition
assessment questionnaire was used to assess the dietary intake of antioxidants, it
relies heavily on the subjects recall biases and estimate of portion size (SamuelHodge et al., 2004; Olendzki et al., 2014). The results of this study should be
interpreted with caution and indeed, the lack of association between 8OHdG and
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dietary antioxidants could have a more favorable outcome if antioxidant levels
were determined from serum or plasma. The study design was observational and
the results may not be interpreted to have causality effect.
Conclusion and Recommendations
This study found inverse relationship between serum MnSOD and
8OHdG; suggesting that serum MnSOD and 8OHdG are useful biomarkers of
oxidative stress in subjects with T2D. We found that there were decreased serum
levels of MnSOD in participants with T2D when compared to participants
without T2D, and that there were elevated levels of 8OHdG present in
participants with T2D indicating higher oxidative stress in persons with T2D.
Additionally, we observed ethnic differences between African
Americans and Haitian Americans with T2D, showing lower oxidative stress
among diabetic Haitian Americans associated with higher intake of dietary
antioxidants. The dietary antioxidants zinc and vitamin C were inversely
correlated with 8OHdG suggesting that dietary intakes of antioxidant may
provide health benefits by reducing mtDNA damage.

88

REFERENCES
Background on Haiti & Haitian Health Culture. (2010). Retrieved March 11,
2014, from http://www.cookross.com/docs/haiti.pdf
Standards of medical care in diabetes. (2014). Retrieved June 20, 2014, from
http://care.diabetesjournals.org/content/37/Supplement_1/S14.full
Abate, M. E., Vatansev, H., & Erkul, L. (2004). Oxidative stress in childhood
obesity. Journal of Pediatric Endocrinology and Metabolism, 17, 10631068.
Abraham, P., Ramamoorthy, H., & Isaac, B. (2013). Depletion of the cellular
antioxidant system contributes to tenofovir disoproxil fumarate – induced
mitochondrial damage and increased oxido-nitrosative stress in the
kidney. Journal of Biomedical Science, 20(1), 61-76.
Akbar, S., Bellary, S., Griffiths, H.R. (2011). Dietary antioxidants inteventions
in T2D patients: a meta-analysis. The British Journal of Diabetes &
Vascular Disease, 11(2), 62-68.
Akbar, S., Bellary, S., Griffiths, H.R. (2003). Dietary Antioxidant Interventions
in T2D Patients: A Meta-analysis. European Journal of Clinical
Nutrition, 57, 999-1008.
Akbaraly, T. N., Ferrie, J. E., Berr, C., Brunner, E. J., Head, J., et al. (2011).
Alternative Healthy Eating Index and mortality over 18 y of follow-up:
results from the Whitehall II cohort. American Journal of Clinical
Nutrition, 94(1), 247-253.
Akihiko, K., Odamaki, M., & Hishida, A. (2003). Blood 8-hydroxy-2′deoxyguanosine is associated with erythropoietin resistance in
haemodialysis patients. Nephrology Dialysis Transplantation, 18(5),
931-936.
Al-Aubaidy H.A. and Jelinek H.F. (2011). Oxidative DNA damage and obesity
in T2D mellitus. European Journal of Endocrinology, 164,899-904.
Alemzadeh, R., Kichler, J., Babar, G., & Calhoun, M. (2008). Hypovitaminosis
D in obese children and adolescents: relationship with adiposity, insulin
sensitivity, ethnicity, and season. Metabolism, 57(2), 183-191.
American Diabetes Association. (2013.). American Diabetes Association home
page. Retrieved from http://diabetes.org
Anderson-Loftin, W., Barnett, S., Bunn, P., Sullivan, P., Hussey, J., Tavakoli, A.
(2005). Soul food light: culturally competent diabetes education.
Diabetes Education, 31(4), 555-563.

89

Andriollo-Sanchez, M., Hininger-Favier, I., Meunier, N., Venneria, E., Oconnor,
J. M., Maiani, G, Coudray, C., & Roussel, A. M. (2005). Age-related
oxidative stress and antioxidant parameters in middle-aged and older
European subjects: the Zenith study. European Journal of Clinical
Nutrition, 59 (suppl. 2), S58-S62.
Arab, L., Cambou, M. C., Craft, N., Wesseling-Perry, K., Jardack, P., & Ang, A.
(2011). Racial differences in correlations between reported dietary
intakes of carotenoids and their concentration biomarkers. The American
Journal of Clinical Nutrition, 93(5),1102-1108.
Bae, Y. S., Oh, H., Rhee, S. G., and Yoo, Y. D. (2011). Regulation of reactive
oxygen species generation in cell signaling. Molecules and Cells, 32(6),
491-509.
Baines, J. W. (2001). Role of oxidative stress in development of complications in
diabetes. Diabetes 40, 405-412.
Basavarai, K. H., Vasu, D. P., & Rao, K. S. (2013). Studies on serum 8-hydroxy
guanosine (8-OHdG) as reliable biomarker for psoriasis. Journal of
European Academy of Dermatology and Venereology, 27(5), 655-657.
Batini-Haberle, I., & Benov, L. (2008). An SOD mimic protects NADP
dependent isocitrate dehydrogenase against oxidative inactivation. Free
Radical Research, 42(7), 843-850.
Bazzano, L. A., Serdula, M., & Liu, S. (2005). Prevention of T2D by diet and
lifestyle modification. Journal of the American College of Nutrition,
24(5), 310-319.
Beauchamp, C., & Fridovich, I. (1971). Superoxide dismutase: improved assays
and an assay applicable to acrylamide gels. Analytical Biochemistry, 44,
276-287.
Block, G., Dietrich, M., Norkus, E. P., Morrow, J. D., Hudes, M., CAfrican
Americans n, B., & Packer, L. (2002). Factors associated with oxidative
stress in human populations. American Journal of Epidemiology, 156,
274-285.
Bolajoko, E., Mossanda, K., Adeniyi, F., Akinosun, O., Fasanmade, A., &
Moropane, M. (2008). Antioxidant and oxidative stress status in T2D and
diabetic foot ulcer. South African Medical Journal, 98(8), 614-617.
Bono, A., Caimi, G., Catania, A., Sarno, A., Pandolfo, L. (1987). Red cell
peroxide metabolism in diabetes mellitus. Hormone and Metabolic
Research, 19, 264-266.

90

Bowling, J., & Katayev, A. (2010). An evaluation of the Roche Cobas c 111.
LabMedicine, 41, 398-402.
Breton J., Sichel F., Bianchini F., & Prevost V. (2003). Measurement of 8hydroxy-2'-deoxyguanosine by a commercially available ELISA test:
Comparison with HPLC/electrochemical detection in calf thymus DNA
and determination in human serum. Analytical Letters, 36, 123-134.
Brownlee M. (2005). The pathobiology of diabetic complications: a unifying
mechanism. Diabetes,54,1615-1625.
Calaf, G. M., Echiburú-Chau, C., Roy, D., Chai, Y., Wen, G., & Balajee, A. S.
(2011). Protective role of curcumin in oxidative stress of breast cells.
Oncology Reports, 26(4), 1029-1035.
Caro, J. J., Ward, A. J., & O’Brien, J. A. (2002). Lifetime costs of complications
resulting from T2D in the U.S. Diabetes Care, 25, 476-481.
Centers for Disease Control and Prevention. (2011). Centers for Disease Control
and Prevention home page. Retrieved from
http://www.cdc.gov/diabetes/statistics/slides/maps_diabetes_trends.pdf
Ceriello, A. (2003). New insights on oxidative stress and diabetic complications
may lead to a “causal” antioxidant therapy. Diabetes Care, 26(5), 15891596.
Ceriello, A. & Motz, E. (2004). Is oxidative stress the pathogenic mechanism
underlying insulin resistance, diabetes, and cardiovascular disease? The
common soil hypothesis revisited. Artheriosclerosis, Thrombosis, and
Vascular Biology, 5(4), 816-823.
Chen, L., Osio, Y. D., & Anderson, J. (1999). Blood antioxidant defense system
and dietary survey of elderly diabetic men. Archives of Gerontology and
Geriatrics, 28(1), 65-83.
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008).
Characterization of microRNAs in serum: a novel class of biomarkers for
diagnosis of cancer and other diseases. Cell Research, 18, 997-1006.
Chatuphonprasert, W., Lao-Ong, T., & Jarukamjorn, K. (2013). Improvement of
superoxide dismutase and catalase in streptozotocin-nicotinamideinduced type 2-diabetes in mice by berberine and glibernclamide.
Pharmaceutical Biology, 2013 Nov 5 [Epub ahead of print].
Clarke, M., Burnett, J., & Croft, K. (2008). Vitamin E in human health and
disease. Critical Reviews in Clinical Laboratory Sciences, 45(5), 417450.

91

Claycamp, H. G. (1993). Phenol sensitization of DNA to subsequent oxidative
damage in 8-hydroxyguanine assays. Carcinogenesis, 13(7), 1289-1292.
Cobianchi, L., Fornoni, A., Ricordi, C., Inverardi, L., Pileggi, A., Molano, R., et
al. (2008). Riboflavin Inhibits IL-6 and p38 Activation in Islet Cells. Cell
Transplantation, 17(5), 559-566.
Cook, M. D., Heffernan, K. S., Ranadive, S., Woods, J. A., and Fernhall, B.
(2013). Effect of resistance training on biomarkers of vascular function
and oxidative stress in young African-American and Caucasian men.
Journal of Human Hypertension, 27(6), 399-392.
Cooke, M. S., Henderson, P. T., & Evans, M. D. (2009). sources of extracellular,
oxidative-modified DNA lesions: Implications for their measurement in
urine. Journal of Clinical Biochemistry and Nutrition, 45(3), 255–270.
Curtis, C., Landis, G. N., Folk, D., Wehr, N. B., Hoe, N., Waskar, M. et al.
(2007). Transcriptional profiling of MnSOD-mediated lifespan extension
of Drosophila reveals a species-general network of aging and metabolic
genes. Genome Biology, 8(12), R262.
De Iuliis, G. N., Thomson, L. K., Mitchell, L. A., Finnie, J. M., Koppers, A. J.,
Hedges, A. (2009). DNA Damage in Human Spermatozoa is Highly
Correlated with Efficiency of Chromatin Remodeling and the Formation
of 8-Hydroxy-2’-Deoxyguanosine, a Marker of Oxidative Stress. Biology
of Reproduction, 81(3), 517-524.
Daien, V., Carriere, I., Kawasaki, R., Cristol, J., Villain, M., Fesler, P. et al.
(2013). Retinal Vascular Caliber is Associated with Cardiovascular
biomarkers of Oxidative Stress and Inflammation: The POLA Study.
PLoS, 8(7), e71089. doi:10.1371/journal.pone.0071089.
Dalle-Donne, I., Rossi, R., Colombo, R, Giustarini, D, and Milzani, A. (2006).
Biomarkers of Oxidative Damage in Human Disease. Clinical
Chemistry, 52(4), 601-623.
Demmer, R. T., Zuk, A. M., Rosenbaum, M., and Desvareaux, M. (2013).
Prevalence of diagnosed and undiagnosed T2D mellitus among US
adolescent: results from the continuous NHANES, 1999-2010.
American Journal of Epidemiology, 178(7), 1106-1113.
Deneke, S. (2000). Thiol-based antioxidants. Current Topics in Cellular
Regulations, 36, 151-180.
Di Naso, F. C., Simoes, D. A., Porawski, M., & Marroni, N. A. (2011).
Exogenous superoxide dismutase: action on liver oxidative stress in
animals with streptozotocin-induced diabetes. Experimental Diabetes

92

Research, vol. 2011, Article ID 754132, 6 pages, 2011.
Doi:10.1155/2011/754132
Du Y., Miller C. M., Kern, T. S. (2003). Hyperglycemia increases mitochondrial
superoxide in retina and retinal cells. Free Radical Biology and
Medicine, 35, 1491-1499.
Earthman, C. P., Beckman, L. M., Masodkar, K., & Sibley, S. D. (2012). The
link between obesity and low circulating 25-hydroxyvitamin D
concentrations: considerations and implications. International Journal of
Obesity, 36(1), 387-396.
Eastridge, D. K. (2009). An integrative review of interventions to reduce
peripheral arterial disease risk factors in African Americans. Journal of
Vascular Nursing, 27(2), 31-45.
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., et al.
(2014). Nutrition Therapy Recommendations for the Management of
Adults with Diabetes. Diabetes Care, 37(suppl.1), S120-S143.
Faghihi, T., Radfar, M., Barmal, M., Amini, P., Qorbani, M., & Larijani, B.
(2013). A Randomized, Placebo-Controlled Trial of Selenium
Supplementation in Patients with T2D: Effects on Glucose Homeostasis,
Oxidative Stress, and Lipid Profile. American Journal of Therapeutics,
2013 April 29 [Epub ahead of print].
Faul, F., Erdfelder, E., Buchner, A., & Lang, A.-G. (2009). Statistical power
analyses using G*Power 3.1: Tests for correlation and regression
analyses. Behavior Research Methods, 41, 1149-1160.
Feairheller, D. L., Diaz, K. M., Sturgeon, K. M., Williamson, S. T., & Brown, M.
D. (2011). Racial differences in the time-course oxidative stress
responses to acute exercise. Journal of Exercise Physiology Online, 14
(1), 49-50.
Fleury, C., Neverova, S., Collins, S., Raimbault, S., Champigny, O., LeviMeyrueis, C., Bouillaud, F., Seldin, M., Surwitt, R., Ricquier, D., &
Warden, C. (1997). Uncoupling-protein-2: a novel gene linked to obesity
and hyperinsulinemia. Nature Genetics, 15, 269-272.
Frei, B. (2004). Efficacy of Dietary Antioxidants to Prevent Oxidative Damage
and Inhibit Chronic Disease. The American Society of Nutritional
Sciences, 134(11), 31965-31985.
Fu, T. Y., Hou, Y. Y., Chu, S. T., Liu, C. F., Huang, C. H., Chen, H. C., Hsiao,
M., Lu, P. J., Wang, J. S., & Ger, L. P. (2011). Manganese superoxide
dismutase and glutathione peroxidase as prognostic markers in patients

93

with buccal mucosal squamous cell carcinomas. Head and Neck, 33(11),
1606-1615.
Garcia-Ramirez, M., Francisco, G., Garcia-Arumi, E., Hernandez, C., Martinez,
R., Andreu, A., et al. (2008). Mitochondrial DNA oxidation and
manganese superoxide dismutase activity in peripheral blood
mononuclear cells from type 2 diabetic patients. Diabetes and
Metabolism, 34(2), 117-124.
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S.
M., Habel, L. A., et al. (2010). Diabetes and Cancer: A consensus report.
Diabetes Care, 33(7), 1674-1685.
Gopaul, N., Manraj, M., Hebe, A., Kwai, S., Yan, S. L., Carrier, M., & Anggard,
E. (2001). Oxidative stress could precede endothelial dysfunction and
insulin resistance in Indian Mauritians and impaired glucose metabolism.
Diabetologia, 44(6), 706-723.
Gorduza, E. V., Indrei, L. L., & Gorduza, V. M. (2008). Nutrigenomics in
postgenomic era. Revista médico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i
Naturaliş̧ti din Iaş̧i, 112(1), 152-164.
Gradinaru, D., Borsa, C., Ionescu, C., Margina, D., Prada, G. I., & Jansen, E.
(2012). Vitamin D status and oxidative stress markers in the elderly with
impaired fasting glucose and T2D mellitus. Aging and Clinical and
Experimental Research, 24(6), 595-602.
Greger, J. L. (1998). Dietary standards for manganese: overlap between
nutritional and toxicological studies. Journal of Nutrition, 128(2 suppl),
368S-371S.
Hakim, I. A., Harris, R., Garland, L., Cordova, C. A., Mikhael, D. M., & SherryChow, H. H. (2012). Gender differences in systemic oxidative stress and
antioxidant capacity in current and former heavy smokers. Cancer
Epidemiology Biomarkers and Prevention, 21(12), 2193-2200.
Han, J., Paik, Y., Yu, J. H., and Kim, H. (2007). Antioxidant nutrientss inhibit
LPS-induced IL-8 expression in human hepatic stellate cells. FASEB
Journal, 21, 855.8
Harman, D. (1956). Aging: a theory based on free radical and radiation
chemistry. Journal of Gerontology, 11, 298-300.
Harri, M., Kasai, H., Mori, T., Tornaeus, J., Savela, K., & Peltonen, K. (2007).
Analysis of 8-hydroxy-2’-deoxyguanosine in urine using high
performance liquid chromatography-electrospray tandem mass
spectrometry. Journal of Chromatography. B, Analytical Technologies in
the Biomedical and Life Sciences, 853(1-2), 242.246.

94

Hassan, H. M., & Schrum, L. (1994). Roles of manganese and iron in the
regulation of the biosynthesis of manganese-superoxide dismutase in
Escherichia coli. FEMA Microbiology Reviews, 14(4), 315-323.
Helliwell, B. (1996). Oxidative stress, nutrition and health, experimental
strategies for optimization of nutritional antioxidant intake in humans.
Free Radical Res., 25, 57-74.
Higdon, J. V. and Frei, B. (2003). Obesity and Oxidative Stress.
Arteriosclerosis, Thrombosis, and Vascular Biology, 23, 365-367.
Hitchler, M. J., Oberley, L. W., & Domann, F. E. (2008). Epigenetic silencing of
SOD2 by histone modifications in human breast cancer cells. Free
Radical Biology and Medicine, 45(11), 1573-1580.
Hitchler, M. J., Wikainapakul, K., Yu, L., Powers, K., Attatippaholkun, W., &
Domann, F. E. (2006). Epigenetic regulation of manganese superoxide
dismutase expression in human breast cancer cells. Epigenetics, 1(4),
163-171.
Huffman, F., Serge, T., & Himburg, S. (2007). Diabetes indicators in Haitian
adults in Miami-Dade County. FASEB Journal, 21, 828.4.
Huffman, F. G., De La Cera, M., Vaccaro, J. A., Zarini, G. G., Exebio, J.,
Gundupalli, D. & Shaban, L. (2011). Healthy Eating Index and
Alternate Healthy Eating Index among Haitian Americans and African
Americans with and without T2D. Journal of Nutrition and Metabolism,
vol. 2011, Article ID 398324, 8 pages, 2011. doi:10.1155/2011/398324
Huffman, F. G., Vaccaro, J., Ajabshir, S., Zarini, G. G., Exebio, J., & Dixon, Z.
(2013). Perceived stress and self-rated health of Haitian and African
Americans with and without T2D. Journal of Research in Medical
Sciences, 18, 198-204.
Ishikawa, T., Fujioka, H., Ishimura, T., Takenaka, A., & Fujisawa, M. (2007).
Increased testicular 8-hydroxy-2’-deguanosine in patients with
varicocele. BJU International, 100(4), 863-866.
Ishikawa, T., Yaginuma, Y., Hayashi, H., Shimizu, T., Endo, Y., & Taniguchi,
N. (1990). Reactivity of a monoclonal antibody to manganese
superoxide dismutase with human ovarian carcinoma. Cancer Research,
50(8), 2538-2542.
Isik, B., Ceylan, A., & Isik, R. (2007). Oxidative stress in smokers and nonsmokers. Inhalation Toxicology, 19(9), 767-769.

95

Izandi, N., Malek, M., Aminian, O., & Saraei, M. (2013). Medical risk factors
of diabetes mellitus among professional drivers. Journal of Diabetes and
Metabolic Disorders, 12(1), 23-26.
Jagetia, G. C., & Aggarwal B. B. (2007). “Spicing up” of the immune system by
curcumin. Journal of Clinical Immunology, 27, 19-35.
Jamil, D., Al-Aubaidy, H., Al-Wasiti, E., & Al Bayati, M. (2014). Evaluating
Markers of Oxidative Stress in Managing Gestational Diabetes Mellitus:
A Cross Sectional Study in Iraq. British Journal of Medicine & Medical
Research, 4(21), 3870-3877.
Jat, D., Parihar, P., Kothari, S. C., & Parihar, M. S. (2013). Curcumin reduces
oxidative damage by increasing reduced glutathione and preventing
membrane permeability transition in isolated brain mitochondria.
Cellular and Molecular Biology, 59 Suppl: OL1899-905.
Johnston, J. W., Pimple, I., Harding, K., & Benson, E. E. (2010). Detection of 8hydroxy-2-deoxyguanosine as a marker of oxidative damage in DNA and
germplasm exposed to cryogenic treatments. Cryo Letters, 31(1), 1-13.
Junqueira, V. B., Barros, S. B., Chan, S., Rodrigues, L., Giavarotti, L., Abud, R.,
& Deucher, G. (2004). Aging and oxidative stress. Molecular Aspects
of Medicine, 25(1-2), 5-26.
Jun, H. S., Kim, I. K., Lee, H. J., Kang, J. H., Kim, J. R., & Shin, H. D. (2009).
Effects of UCP2 and UCP3 variants on the manifestation of overweight
in Korean Children. Obesity, 17(2), 355-362.
Kallio, P., Kolehmainen, M, L., Ksonen, D.E., Keka¨la¨inen, J., Salopuro, T.,
Sivenius, K., Pulkkinen, L., Mykka¨nen, H. M., Niskanen, L., et al.
(2007). Dietary carbohydrate modification induces alterations in gene
expression in abdominal subcutaneous adipose tissue in persons with the
metabolic syndrome: The FUNGENUT Study 1-4. The American Journal
of Clinical Nutrition, 85, 1417-1427.
Kaminski, M. M., Roth, D., Sass, S., Sauer, S. W., Krammer, P. H., & Gulow, K.
(2012). Manganese superoxide dismutase: A regulator of T cell
activation-induced oxidative signaling and cell death. Biochimica et
Biophysica Acta, 1823(5), 1041-1052.
Kannan K., & Jain, S. K. (2000). Oxidative stress and apoptosis.
Pathophysiology, 7(3), 153-163.
Karter, A. J., Ferrara, A., Liu, J. Y., Moffet, H. H., Ackerson, L. M., & Selby J.
V. (2002). Ethnic disparities in diabetic complications in an insured
population. Journal of American Medical Association, 287, 2519-2527.

96

Kato, A., Odamaki, M., & Hishida, A. (2003). Blood 8-hydroxy2’deoxyguanosine is associated with erythropoietin resistance in
haemodialysis patients. Nephrology, Dialysis, and Transplantation, 18,
931-936.
Kazi, T. G., Afridi, H. I., Kazi, N., Jamali, M. K., Arain, M. B., Jalbani, N., &
Kandhro, G. A. (2008). Copper, chromium, manganese, iron, nickel, and
zinc levels in biological samples of diabetes mellitus patients. Biological
Trace Elements Research, 122(1), 1-18.
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002). Dysfunction of
mitochondria in human skeletal muscle in T2D. Diabetes, 51(10), 29442950.
Khadem-Ansari, M., Shahsavari, Z., Rasmi, Y., & Mahmoodlo, R. (2011).
Elevated levels of urinary 8-hydroxy-2’-deoxyguanosine and 8isoprostane in esophageal squamous cell carcinoma. Journal of
Carcinogenesis, 10, 14.
Khan, S., Raghuram, G. V., Bhargava, A., Pathak, N., Chandra, D. H., Jain, S.
K., Mishra, P. K. (2011). Role and clinical significance of lymphocyte
mitochondrial dysfunction in T2D mellitus. Translational Research, 8(6),
344-358.
Kikuchi, A., Takeda, A., Onodera, H., Kimpara, T., Sato, N., Nunomura, A.,
Castellani, R. J., Perry, G., Smith, M. A., & Itoyama, Y. (2002).
Systemic increase of oxidative nucleic acid damage in Parkinson’s
disease and multiple system atrophy. Neurobiological Disease, 9(2),
244-248.
Kim, G., & Caprio, S. (2011). Diabetes and insulin resistance in pediatric
obesity. Pediatric Clinics of North America, 58(6), 1355-1361.
Kirk J.K., D'Agostino R.B., Jr, Bell R.A., Passmore L.V., Bonds D.E., Karter
A.J., Narayan K.M. (2006). Disparities in A1C levels between AfricanAmerican and non-Hispanic white adults with diabetes: a meta-analysis.
Diabetes Care 29, 2130–2136.
Kiss, L., & Szabo, C. (2005). The pathogenesis of diabetic complications: the
role of DNA injury and poly (ADP-ribose) polymerase activation in
peroxynitrite-mediated cytotoxicity. Memórias do Instituto Oswaldo
Cruz, 100(Suppl. 1), 29-37.
Kowluru, R., Atasi, L., & Ho, Y. (2006). Role of mitochondrial superoxide
dismutase in the development of diabetic retinopathy. Investigative
Ophthamology and Visual Science, 47(4), 1594-159.

97

Kozirog, M., Poliwczak, A., Duchnowicz, P., Koter-Michalak, M., Sikora, J., &
Broncei, M. (2010). Melatonin treatment improves blood pressure, lipid
profile, and parameters of oxidative stress in patients with metabolic
syndrome. Journal of Pineal Research (Wiley Online Library). Retrieved
from http://onlinelibrary.wiley.com/doi/10.1111/j.1600079X.2010.00835.x/full
Kumar, P. R., Bhansali, A., Ravikiran, M., Bhansali, S., Dutta, P., Thakur, J. S.,
Sachdeva, N., Bhadada, S. K., and Walia, R. (2010). Utility of glycated
hemoglobin in diagnosing T2D mellitus: a community-based study.
Journal of Clinical Endocrinology and Metabolism, 95(6), 2832-2835.
Landete, J. M. (2013). Dietary intake of natural antioxidants: vitamins and
polyphenols. Critical Reviews in Food Science and Nutrition, 53(7),
706-721.
Larsen, S., Stride, N., Hey-Mogensen, M. Hansen, C. N., Anderson, J. L.,
Madsbad, S., et al. (2011). Increased mitochondrial substrate sensitivity
in skeletal muscle of patients with T2D. Diabetologia, 54(6), 1427-1436.
Larsen, T. M., Stine-Mathilde, D., Van Baak, M., Jebb, S.A., Papadaki, A., et al.
(2010). Diets with High or Low Protein Content and Glycemic Index for
Weight-Loss Maintenance. New England Journal of Medicine, 363(1),
2102-2113.
Lee, E. S., Corfe, B. M., & Powers, H. J. (2013). Riboflavin depletion of
intestinal cells in vitro leads to impaired energy generation and enhanced
oxidative stress. European Journal of Nutrition, 52(5), 1513-1521.
Lee, S. F., & Pervaiz, S. (2011). Assessment of oxidative stress-induced DNA
damage by immunoflourescent analysis of 8-OxodG. Methods in Cell
Biology, 103, 99-113.
Lemacks, J., Wells, B. A., Ilich, J. Z., & Ralson, P. A. (2013). Interventions for
Improving Nutrition and Physical Activity Behaviors in Adult African
American Populations: A Systematic Review, January 2000 Through
December 2011. Prevention of Chronic Disease, 10:120256. DOI:
http://dx.doi.org/10.5888/pcd10.120256.
Li, C., & Zhou, H. M. (2011). The role of manganese superoxide dismutase in
inflammation defense. Enzyme Research, V2011, article ID 387176, 6
pages.
Lin Y., Kikuchi, S., Obata, Y., & Yagyu, K. A case-control study exploring the
role of serum manganese superoxide dismutase (MnSOD) levels in
gastric cancer. Journal of Epidemiology, 15(3), 90-95.

98

Liburd, L. C. (2003). Food, Identity, and African American Women with T2D:
An Anthropological Perspective. Diabetes Spectrum, 16(3), 160-165.
Liutkeviciene, R., Lesauskaite, V., Asmoniene, V., Zaliūniene, D., & Jasinskas,
V. (2010). Factors determining age-related macular degeneration: A
current view. Medicina, 46(2), 89-94.
Lin, Y., Kikuchi, S., Obata, Y., & Yagyu, K. (2005). A case-control study
exploring the role of serum manganese superoxide dismutase (MnSOD)
levels in gastric cancer. Journal of Epidemiology, 15(3), 90-95.
Loft, S., Vistisen, K., Ewertz, M, Tjonneland, A., Overvad, K., and Poulsen,
H.E. (1992). Oxidative DNA damage estimated by 8hydroxydeguanosine excretions in humans: influence of smoking, gender,
and body mass index. Carcinogenesis, 13(12), 2241-2247.
Looker, H. C., Knowler, W. C., & Hanson, R. L. (2001). Changes in BMI and
Weight Before and After the Development of T2D. Diabetes Care,
24(11), 1917-1922.
Luke, A., Durazo-Arvizu, R., Rotimi, C., Prewitt, T. E., Forrester, T., Wilks, R.,
Ogunbiyi, O. J., Schoeller, D. A., McGee, D., and Cooper, R. S. (1997).
Relationship between Body Mass Index and Body Fat in Black
Population Samples from Nigeria, Jamaica, and the United States.
American Journal of Epidemiology, 155(7), 620-628
Lumini, J., Magalhaes, J., Oliveira, P., & Ascensao, A. (2008). Beneficial effects
of exercise on muscle mitochondrial function in diabetes mellitus. Sports
Medicine, 38(9), 7335-7350.
Madsen-Bouterse, S. A., Zhong, Q., Mohammad, G., Ho, Y. S., & Kowluru, R.
A. (2010). Oxidative damage of mitochondrial DNA in diabetes and its
protection by manganese superoxide dismutase. Free Radical Research,
44(3), 313-321.
Manickam, B., Neagu, V., & Barengolts, E. (2013). Relationship between
glycated hemoglobin and circulating 25-hydroxyvitamin D concentration
in African American and Caucasian American men. Endocrine Practice,
19(1), 73-80.
Marling, C. R., Shubrook, J. H., Vernier, S. J., Wiley M. T., & Schwartz, F. L.
(2011).Characterizing blood glucose variability using new metrics with
continuous glucose monitoring data. Journal of Diabetes Science and
Technology, 5(4), 871-878.
Martin-Timon, I., Sevillano-Collantes, S., Sergura-Galindo, A. & del CanizoGomez, F. J. (2014). T2D and cardiovascular disease: Have all risk
factors the same strength? World Journal of Diabetes, 5(4), 444-470.

99

Martini, L., Catania, A., & Ferreira, S. (2010). Role of vitamins and minerals in
prevention and management of T2D mellitus. Nutrition Reviews, 68(6),
341-354.
McCullough, M. L., Feskanich, D., Stampfer, M. J., Giovannucci, E. L., Rimm,
E. B., Hu, F. B., et al. (2002). Diet quality and major chronic disease
risk in men and women: moving toward improved dietary guidance.
American Journal of Clinical Nutrition, 76(6), 1261-1271.
Mayor, S. (2007). International Diabetes Federation consensus on prevention of
T2D. International Journal of Clinical Practice, 61(10); 1773-1775.
Miller, J., Chu, Y., Brooks, R., Richenbacher, W., Pena-Silva, R., & Heistad, D.
(2008). Dysregulation of antioxidant mechanisms contributes to increased
oxidative stress in calcific aortic valvular stenosis in humans. Journal of
American College of Cardiology, 52(10), 843-850.
Miph, V., der Ploeg, H. V., Cheung, N., Dphil, R. H., & Bauman, A. (2008).
Sociodemographic correlates of the increasing trend in prevalence of
gestational diabetes in a large population of women between 1995 and
2005. Diabetes Care, 31(12), 2288-2293.
Miriyala, S., Spasojevic, I., Tovmasyan, A., Salvemini, D., Vujaskovic, Z., St.
Claire, D., & Batinic-Heberle, I. (2012). Antioxidants and antioxidant
treatment in disease. Biochemica and Biochemica Acta, 1822(5), 794814.
Moller, P., Wallin, H., & Knudsen, L. E. (1996). Oxidative stress associated
with exercise, psychological stress and life-style factors. ChemicoBiological Interactions, 102(1), 17-36.
Moller, P. & Loft, S. (2002). Oxidative DNA damage in human white blood
cells in dieatry antioxidant intervention studies. The American Journal of
Clinical Nutrition, 76(2), 303-310.
Montonen, J., Järvinen, R., Knekt, P., & Reunanen, A. (2004). Dietary
antioxidant intake and risk of T2D. Diabetes Care, 27, 362-366.
Morris, M.C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A.,
Aggarwal, N., Wilson, R. S., and Scherr, P. A. (2002). Dietary Intake of
Antioxidant Nutrients and the Risk of Incident Alzheimer Disease in a
Biracial Community Study. Journal of American Medical Association,
287(24), 3223-3261.
Morris, A. A., Zhao, L., Patel, R. S. , Jones, D. P., Ahmed, Y., Stoyanova, N. ,
Gibbons, G. H., Vaccarino, V., Din-Dzietham, R., & Quyyumi, A. A.
(2012). Differences in system oxidative stress based on race and the
metabolic syndrome: the Morehouse and Emory Team up to Eliminate

100

Health Disparities (META-Health) study. Metabolic Syndrome Related
Disorders, 10(4), 252-259.
Mullner, E., Brath, H., Pleifer, S., Schiemayr, Baierl, A. et al. (2013).
Vegetables and PUFA-rich plant oil reduce DNA strand breaks in
individual with T2D. Molecular Nutrition and Food Research, 57(2),
328-338.
Nakhjavani, M., Morteza, A., Meysamie, A., Esteghamati, A., Khalilzadeh, O.,
et al. (2010). Serum heat shock protein 70 and oxidized LDL in patients
with T2D: does sex matter? Cell Stress and Chaperones, 16(2), 195-201.
Nishidi, T., Sugiyama, T., Kataoka, A., Tashiro, M., Yakushiji, M., & Isahikawa,
M. (1993). Serum manganese superoxide dismutase (MnSOD) and
histological virulence of ovarian cancer. Asia Oceania Journal of
Obstetric and Gynecology, 19(4), 427-431.
National Cholesterol Education Program. (2011). National Institute of Health
homepage. Retrieved from http://www.nhlbi.nih.gov/index.htm
Niki, E. (2013). Role of vitamin E as a lipid-soluble peroxyl radical scavenger:
in vitro and in vivo evidence. Free Radical Biology and Medicine, 66, 312.
Nishida, T., Sugiyama, T., Kataoka, A., Tashior, M., Yakushiji, M., and
Ishikawa, M. (1993). Serum manganese superoxide dismutase
(MnSOD) and histological virulence of ovarian cancer. Asia Oceania
Journal of Obstetrics and Gynecology, 19(4), 427-431.
O’Brien, J. A., Patrick, A. R., & Caro, J. (2000). Estimates of direct medical
costs for microvascular and macrovascular complications resulting from
T2D mellitus in the United States in 2000. Clinical Therapeutics, 25,
1017-1038.
O’Connor, P. J., Bodkin, N. L., Fradkin, J., Glasgow, R. E., et al. (2011).
Diabetes performance measures: Current status and future directions.
Diabetes Care, 34(7), 1651-1659.
Ofili, E. (2001). Ethnic disparities in cardiovascular health. Ethnicity and
Disease, 11(4), 838-840.
Olendzki, B. C., Ma, Y., Hebert, J. R., Pagoto, S. L., Merriam, P. A., Rosal, M.
C., & Ockene, I. S. (2008). Underreporting of energy intake and
associated factors in a Latino population at risk of developing T2D.
Journal of American Dietetic Association, 108(6), 1003-1008.
Omori, K., Ohira, T., Uchida, Y., Ayilavarapu, S., Batista, E., Yagi, M., et al.
(2008). Priming of neutrophil oxidative burst in diabetes requires

101

preassembly of the NADPH oxidase. Journal of Leukocyte Biology,
84(1), 292-301.
Osawa, T., & Kato, Y. (2005). Protective role of antioxidative food factors in
oxidative stress caused by hyperglycemia. Annals of the New York
Academy of Science, 1043, 440-451.
Otsu, K., Ikeda, Y., & Fujii, J. (2004). Accumulation of manganese superoxide
dismutase under metal-depleted conditions: proposed role of zinc ions in
cellular redox balance. Biochemical Journal, 377(1), 241-248.
Pacifico, L., Anania, C., Osborn, J. F., Ferraro, F., Bonci, E., Olivero, E., et al.
(2011). Low 25(OH)D3 levels are associated with total adiposity,
metabolic syndrome, and hypertension in Caucasian children and
adolescents. European Journal of Endocrinology, 161(5), 603-611.
Pagano, G., Talamanca, A. A., Castello, G., Cordero, M. D., d’Ishia, M., et al.
(2014). Oxidative Medicine and Cellular Longevity, vol. 2014, Article

ID 541230, 27 pages, 2014. doi:10.1155/2014/541230
Palmeira, C., Rolo, A., Berthiaume, J., Bjork, J., & Wallace, K. (2007).
Hyperglycemia decreases mitochondrial function: the regulatory role of
mitochondrial biogenesis. Toxicology and Applied Pharmacology,
225(2), 214-220.
Pan, H. Z., Zhang, H., Chang, D., Li, H., & Sui, H. (2008). The change of
oxidative stress products in diabetes mellitus and diabetic retinopathy.
British Journal of Ophthamology, 92(4), 548-551.
Pan, W. H., Flegal, K. M., Chang, W. Y., Yeh, W. T., Yeh, C. J., and Lee, W.C.
(2004). Body mass index and obesity-related metabolic disorders in
Taiwanese and US whites and blacks: implications for definitions of
overweight and obesity for Asians. American Journal of Clinical
Nutrition, 79(1), 31-39.
Park, K.S., Kim, J.H., Kim, M.S., Kim, J.M., Kim, S.K., et al. (2001). Effects of
Insulin and Antioxidant on Plasma 8-Hydroxyguanine and Tissue 8Hydroxydeoxyguanosine in Streptozotocin-Induced Diabetic Rats.
Diabetes, 15(12), 2837-2841.
Patel, P. R., Bevan R. J., Mistry, N., & Lunec, J. (2007). Evidence of
oligonucleotides containing 8-hydroxy-2’-deoxyguanosine in human
urine. Free Radical and Biological Medicine, 42(4), 552-558.
Pereira, E., Ferderbar, S., Bertolami, M., Faludi, A., Monte, O., Xavier, H., et al.
(2008). Biomarkers of oxidative stress and endothelial dysfunction in
glucose tolerance and diabetes mellitus. Clinical Biochemistry, 41(18),
1454-1460.

102

Phillips, M., Cataneo, R. N., Cheema, T, & Greenberg, J. (2004). Increased
breath biomarkers of oxidative stress in diabetes mellitus. Clinica
Chimica Acta, 344, 189-194.
Pitocco, D., Zaccardi, F., Di Stasio, E., Romitelli, F., Santini, S.A., Zuppi, C., &
Ghirlanda, G. (2010). Oxidative stress, nitric oxide, and diabetes. The
Review of Diabetic Studies, 7(1), 15–25.
Poljsak, B. & Fink, R. (2014). The protective role of antioxidants in the defence
against ROS/RNS-mediated environmental pollution. Oxidative
Medicine and Cellular Longevity, vol. 2014, Article ID 671539, 22
pages, 2014. doi:10.1155/2014/671539
Pun, P. B. L. & Murphy, M. P. (2012). Pathological Significance of
Mitochondrial Glycation,” International Journal of Cell Biology, vol.
2012, Article ID 843505, 13 pages, 2012. doi:10.1155/2012/843505
Pryor, W.A. (1997). Cigarette smoking radicals and the role of free radicals in
chemical carcinogenicity. Environmental Health Perspect, 105(1), 875882.
Pylvas, M., Puistola, U., Laatio, L., Kauppila, S., & Karihtala, P. (2011).
Elevated serum 8-OHdG is associated with poor prognosis in epithelial
ovarian cancer. Anticancer Research, 31(4), 1411-1415.
Racial and Ethnic Health Disparities in Miami-Dade County. (2008). Retrieved
from http://www.dadehealth.org/downloads/Racial and Ethnic Health
Disparities in Miami-Dade.pdf
Rains, J. L., & Jain, S. K. (2011). Oxidative stress, insulin signaling, and
diabetes. Free Radical Biology and Medicine, 50(5), 567-575.
Ramos, L. F., Shintani, A., Ikizler, T. A., and Himmelfarb, J. (2008). Oxidative
Stress and Inflammation Are Associated with Adiposity in Moderate to
Severe CKD. Journal of American Society of Nephrology, 19(30), 593599.
Reddi, A. G., & Culotta, V. C. (2011). Regulation of manganese antioxidants by
nutrient sensing pathways in saccharomyces cerevisiae. Genetics
(epublication, ahead of print copy).
Ren, C. J., Zhang, Y., Cui, W. Z., & Mu, Z. M. (2013). Progress in the role of
oxidative stress in the pathogenesis of T2D. Acta Physiologica Sinica,
65(6), 664-673.
Rhee, M. K., Cook, C. B., Dunbar, V. G., Panayioto, R. M., Berkowitz, K. J.,
Boyd, B. G., George, C. D., Lyles, R. H., El-Kebbi, I. M., & Phillips,
L.S. (2005). Limited health care access impairs glycemic control in low

103

income urban African Americans with T2D. Journal of Health Care for
the Poor and Underserved, 16, 734-746.
Richard, P., Alexandre, P. K., Lara, A., Akamigbo, A. B. (2011). Racial and
ethnic disparities in the quality of diabetes care in a nationally
representative sample. Preventing Chronic Disease, 8(6), A142.
Rolo, A., & Palmeira, C. (2006). Diabetes and mitochondrial function: Role of
hyperglycemia and oxidative stress. Toxicology and Applied
Pharmacology, 212(2), 167-178.
Rosen, A., Sharpe, I., Rosen, J., Doddard, M., & Abad, M. (2007). The
prevalence of T2D in the Miami-Haitian community. Ethnicity and
Disease,7, S3-S4.
Ruchko, M. K., Gorodnya, O. M., Zuleta, A., Pastukh, V. M., & Gillespie, M. N.
(2011). The DNA glycosylase Ogg1 defends against oxidant-induced
mtDNA damage and apoptosis in pulmonary artery endothelial cells.
Free Radical Biology and Medicine, 50(9), 1107-1113.
Sadi, G., Eryilmaz, N., Tütüncüoğlu, E., Cingir, S., & Güray, T. (2011). Changes
in expression profiles of antioxidant enzymes in diabetic rat kidneys.
Diabetes/Metabolism Research and Reviews (epublication, ahead of print
copy). doi:10.1002/dmrr.1302
Saedisomeolia, A., Taheri, E., Djalali, M., Qorbani, M., Rajab, A., & Larijani, B.
(2013). Vitamin D status and its association with antioxidant profiles in
diabetic patients: A cross-sectional study in Iran. Indian Journal of
Medical Sciences, 67(1), 29-37.
Saleh, M. C., Wheeler, M. B., & Chan, C. B. (2002). Uncoupling protein-2:
evidence for its function as a metabolic regulator. Diabetologia, 45, 174187.
Salem, S.I., El-Toukhy, S.E., El-Saeed, G.S, and El-Wassef, M. (2012)
Correlation of DNA damage in T2D to glycemic control. Egyptian J of
Hosp Med, 48, 472-482.
Samuel-Hodge, C. D., Fernandez, L. M., Henriquez-Roldan, C. F., Johnston, L.
F., & Keyserling, T. C. (2004). A Comparison of Self-Reported Energy
Intake with Total Energy Expenditure Estimated by Accelerometer and
Basal Metabolic Rate in African American Women with T2D. Diabetes
Care, 27(3), 663-669.
Savini, I., Catani, M. V., Evangelista, D., Gasperi, V., and Avigliano, L. (2013).
Obesity-Associated Oxidative Stress: Strategies Finalized to Improve
Redox State. International Journal of Molecular Sciences, 14, 1049710538.

104

Schadendor, D., Zuberbier, T., Diehl, S., Schadendorf, C., and Czametzki, B. M.
(1995). Serum manganese superoxide dismutase is a new tumor marker
for malignant melanoma. Melanoma Research, 5(5), 351-353.
Schramm, M., Wiegmann, K., Schramm, S., Gluschko, A., Herb, M.,
Utermohlen, O., Kronke, M. (2013). Riboflavin (vitamin B2) deficiency
impairs NADPH oxidase 2 (Nox2) priming and defense against listeria
monocytogenes. European Journal of Immunology (Wiley Online
Library), retrieved from
http://onlinelibrary.wiley.com/doi/10.1002/eji.201343940/full
Serrano, N .C., Díaz, L. A., Casas, J. P., Hingorani, A.D., Moreno de Lucca, D.,
& Páez, M. C. (2010). Frequency of eNOS polymorphisms in the
Colombian general population. BMC Genetics, 20, 11, 54.
Shai, I., Jiang, R., and Manson, J. E., Stampfer, M. J., Willett, W. C., Colditz, G.
A., and Hu, F. B. (2006). Ethnicity, obesity, and risk of T2D in women:
a 20 year follow-up study. Diabetes Care, 29(7), 1585-1590.
Shen, X., Zheng, S., Metreveli, N. S., and Epstein, P. N. (2006). Protection of
Cardiac Mitochondria by Overexpression of MnSOD Reduces Diabetic
Cardiomyopathy. Diabetes, 55(3), 798-805.
Siddiqi, Z., Tiro, J. A., & Shuval, K. (2011). Understanding impediments and
enablers to physical activity among African American adults: A
systematic review of qualitative studies. Health Education Research,
26(6), 1010-1024.
Siedlak, S. L., Cassadeus, G., & Perry, G. (2009). Chronic antioxidant therapy
reduces oxidative stress in a mouse model with Alzheimer’s disease.
Free Radical Research, 43(2), 156-164.
Skelly, A. H., Carlson, J., Leeman, J., Soward, A., & Burns, D. (2009).
Controlled Trial of Nursing Interventions to Improve Health Outcomes of
Older African American Women with T2D. Nurse Research, 58(6), 410418.
Soini, Y., Turpeenniemi-Hujanen, T., Kärjä, V., Karihtala, P. (2011). 8hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary
bladder carcinoma. International Journal of Clinical and Experimental
Pathology, 4(3), 267-275.
Soper, D. S. (2011) A-priori sample size calculator for multiple regression
[Online software]. Retrieved from http://www.danielsoper.com/statcalc3
Suksomboon, N., Poolsup, N., & Sinprasert, S. (2011). Effects of vitamin E
supplementation on glycemic control in T2D: Systematic review of

105

randomized controlled trials. Journal of Clinical Pharmacy and
Therapeutics, 36(1), 53-63.
Suzuki, S., Hinokio, Y., Toyota, T., Komatu, K., Ohtomo, M., Onoda, M., et al.
(1999). Oxidative damage to mitochondrial DNA and its relationship to
diabetic complications. Diabetes Research and Clinical Practice, 45(23), 161-168.
Suzuki, H., Usui, I., Kato, I., Oya, T., Kanatani, Y., Yamazaki, Y., Fujisaka, S.,
Senda, S., Ishi, Y., Urakaze, M., Mahmood, A., Takasawa, S., Okamoto,
H., Kobayashi, M., Tobe, I., & Sasahara, M. (2001). Deletion of plateletderived growth factor receptor-β improves diabetic nephropathy in
Ca²⁺ /calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic
mice. Diabetologia, 54(11), 2953-2962.
Tamai, T., Uto, H., Takami, Y., Oda, K., Saishoji, A., Hashiquchi, M., Kumagai,
K., et al. (2011). Serum manganese superoxide dismutase and
thioredoxin are potential prognostic markers for hepatitis C virus-related
hepatocellular carcinoma. World Journal of Gastroentrology, 17(44),
4890-4898.
Tan, X., Poulose, E. M., Raveendran, V. A., Zhu, B. T., Stechschulte, D. J., &
Dileepan, K. N. (2011). Regulation of the expression of cyclooxygenases
and production of prostaglandin I and E in human coronary artery
endothelial cells by curcumin. Journal of Physiology and Pharmacology,
62(1), 21-28.
Tuomilehto, J., Schwarz, P., & Lindstrom, J. (2011). Long-Term Benefits From
Lifestyle Interventions for T2D Prevention. Diabetes Care, 34(2), 210214.
United States Department of Commerce. (2009). United States Census Bureau.
Retrieved from http://census.gov
Unnikrishnan, R., Anjana, R. M., and Mohan, V. (2012). Drugs affecting
HbA1c levels. Indian Journal of Endocrinology and Metabolism, 16(4),
528-531.
Vanuzzo, D., Pilotto, L., Mirolo, R., & Pirelli, S. (2008). Cardiovascular risk and
cardiometabolic risk: An epidemiological evaluation. Giornale Italiano di
Cardiologia, 9(4 Suppl. 1), 6S-S17.
Van Voorhis, W., & Morgan, B. L. (2007). Understanding power and rules of
thumb for determining sample sizes. Tutorials in Quantitative Methods
for Psychology, 3(2), 43-50.
VanEewyk, J. (2010). Guidelines for Using Racial and Ethnic Groupings in
Data Analyses. State Epidemiologist for Non-Infectious Conditions.

106

Revision Date: April 30, 2010. Retrieved from:
http://www.doh.wa.gov/Portals/1/Documents/5500/RaceEthnGuidelines.
pdf
Vimalananda, V.G., Rosenzweig, J.L., Cabral, H.J., David, M.M., and Lasser,
K.E. (2011). Comparison of Diabetes Control Among Haitians, African
Americans, and Non-Hispanic Whites in an Urban Safety-Net Hospital.
Diabetes Care, 34(1), 58-60.
Vina, J., Gambini, J., Lopez-Gueso, R., Abdelaziz, K. M., Jove, M., & Borras, C.
(2011). Females live longer than males: a role of oxidative stress.
Current Pharmaceutical Design, 17(36), 3959-3965.
Warolin, J., Coenen, K. R., Kantor, J. L., Whitaker, L. E., Wang, L., Acra, S. A.,
Roberts, L. J. 2nd, & Buchowski, M. S. The relationship of oxidative
stress, adiposity, and metabolic risk factors in healthy Black and white
American youth. Pediatric Obesity, 9(1), 43-52.
Walter Jr., R. M., Uriu-Hare, J. Y., Olin, K. L., Oster, M. H., Anawalt, B. D.,
Critchfield, J. W., and Keen, C. L. (1991). Copper, Zinc, Manganese,
and Magnesium Status and Complications of Diabetes Mellitus. Diabetes
Care, 14(11), 1050-1056.
Watters, J. L., Satia, J. A., & Kupper, L. L. (2008). Correlates of antioxidant
nutrients and oxidative DNA damage differ by race in a cross-sectional
study of healthy African American and white adults. Nutrition Research,
28(9), 565-576.
Watters, J. L., Satia, J. A., Kupper, L. L., Swenberg, J. A., Schroeder, J. C., &
Switzer, B. R. (2007). Associations of Antioxidants Nutrients and
oxidative DNA damage in healthy African American and White adults.
Cancer, Epidemiology, Biomarkers and Prevention, 16, 1428-1436.
Wegner, M., Rawluszko-Wieczorek, A. A., Piorunska-Stolzmann, M.,
Zozulinksa-Zolkiewicz, d., Wierusz-Wysocka, B. & Jagodzinski, P.
(2014). Expression of mitochondrial superoxide dismutase in
polymorphonuclear leukocytes from type 1 diabetes patients with and
without microvascular complications. Polskie Archiwum Medycyny
Wewnetrznej, 2014 Apr 15 [Epub ahead of print].
Weissenberger, J., Priester, M., Bernreuther, C., Rakel, S., Glatzel, M., Seifert,
V., & Kögel, D. (2010). Dietary curcumin attenuates glioma growth in a
syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling
pathway. Clinical Cancer Research, 16(23), 5781-5795.
Wen, X., Wu, J., Wang, F., Liu, B., Huang, C., & Wei, Y. (2013).
Deconvoluting the role of reactive oxygen species and autophagy in
human disease. Free Radical Biology and Medicine, 65(1), 401-410.
107

West, I. (2000). Radicals and oxidative stress in diabetes. Diabetic Medicine, 17,
171-180.
Whaley-Connell, A. & Sowers, J.R. (2012). Oxidative stress in the cardiorenal
metabolic syndrome. Current Hypertension Reports, 14(4), 360-365.
WHO. World Health Organization Fact Sheet for World Wide Prevalence of
Obesity. Retrieved from
www.who.int/mediacentre/factsheets/fs311/en/indexhtml (accessed on
June 23rd, 2014).
Willet, W. C., Sampson, L., Stampfer, M. J., Rosner, B., Bain, C., Witschi, J.,
Hennekens, H., & Speizer, F. E. (1985). Reproducibility and validity of a
semi quantitative food frequency questionnaire. American Journal of
Epidemiology, 122, 51-65.
Wonisch, W., Falk, A., Sundl, I., Winklhofer-Roob, B. M., & Lindschinger, M.
(2012). Oxidative stress increases continuously with BMI and age with
unfavourable profiles in males. The Aging Male, 15(3), 159-185.
Wright, E. Jr., Scism-Bacon, J. L., & Glass, L. C. (2006). Oxidative stress in
T2D: the role of fasting and postprandial. International Journal of
Clinical Practice, 60(3), 308-314.
Wu, L., Chiou, C., Chang, P., & Wu, J. (2004). Urinary 8OHdG: A marker of
oxidative stress to DNA and risk factor for cancer, atherosclerosis and
diabetes. Clinica Chimica Acta, 339(1-2), 1-9.
Xu, G., Yao, Q., Weng, Q., Su, B., Zhang, X., & Xiong, J. (2004). Study of
urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA
damage in diabetic nephropathy patients. Journal of Pharmaceutical and
Biomedical Analysis, 36(1), 101-104.
Yoshida, M., Ogawa, Y., Kasai, H. (2003). Urinary 8-oxo-7, 8-dihydro- 2’deoxyguanosine values measured by an ELISA correlated well with
measurements by high performance liquid chromatography with
electrochemical detection. Cancer Epidemiology Biomarkers and
Prevention, 11, 1076-1081.
Zhong, Q., & Kowluru, R.A. (2011). Epigenetic changes in mitochondrial
superoxide dismutase in the retina and the development of diabetic
retinopathy. Diabetes, 60(4), 1304-1313.
Ziemer, D. C., Kolm, P., Weintraub, W. S., Vaccarino, V., Rhee, M. K.,
Twombly, J. G., Narayan, K. M., Koch, D. D., & Phillips, L. S. (2010).
Glucose-independent, black-white differences in hemoglobin A1c: a
cross-sectional analysis of 2 studies. Annals of Internal Medicine,
152(12), 770-777.

108

Zhu, H., Jia, Z., Misra, H., & Li, Y. R. (2012). Oxidative stress and redox
signaling mechanisms of alcoholic liver disease. Updated experimental
and clinical evidence. Journal of Digestive Disease, 13(3), 133-142.

109

APPENDICES
Appendix A: Recruitment Flyer (English version)
Appendix B: Recruitment Flyer (Creole version)
Appendix C: Florida International University IRB Approval
Appendix D: Form A- For Initial Submission for IRB Approval
Appendix E: IRB Exemption Memorandum
Appendix F: Harvard Food Frequency Questionnaire
Appendix G: Socio-demographic Questionnaire
Appendix H: Document to collect measured parameters
Appendix I

Summary of study method

110

APPENDIX A

111

Cardiovascular Disease Risk
Study
in Haitian & African-American
You are invited to participate in a study
conducted at Florida International
University
by Dr. Fatma G. Huffman
Criteria to enroll:





You must be Haitian or African-American
You must be 35 years old or older
You must agree to give three tablespoons of blood to
test glucose levels and other biochemical tests
You must agree to give a urine sample

You will receive information on your diet, physical
activity level, body mass index, blood pressure and
laboratory blood analysis. The whole process generally
takes 3 hours.
You will receive $ 75.00 upon completion of the study
For information, please contact:
Dr. Fatma G. Huffman: 305-348-6427 or huffmanf@fiu.edu
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Etid sou maladi Kadiovaskilè Lakay
Ayisyen ak Afriken-Amériken
Nou invité ou pou ou kapab patisipé nan yon
étid Ké Dr. Fatma G. Huffman ap fè Nan
Florida International Université
Kondisyon pou kapab patisipé nan étid sa-a:





Ou sipozé Ayisyen ou byen Afriken-Amériken
Ou sipozé genyen 35 ans ou plis
Aksepté ké yo pran kèk gout san sou ou min-m pou yo
kapab tchéké sik ou avèk lòt analiz nan san ou.
Aksepté pou ou bay yon ti échantiyon pipi

Konsiltasyon a ap dire 3 zè de tan. Nan moman sa a,wap
résévwa enfomasyon sou dayèt ou, enfomasyon sou aktivité
fisik ou, enfomasyon sou tensyon ou, plis lòt résilta
laboratwa.
Kòm rékompans wap résévwa $75 pou patisipasyon ou
Pou plis enfomasyon sou étid la, ou kapab kontakté:
Dr. Fatma G. Huffman: 305-348-6427 or huffmanf@fiu.edu
Gustavo Zarini: 305-348-6427 or gzarini@hotmail.com
Erskine Clerjeune: 786-355-4589 or eclerjeune@yahoo.com
E. Nelson: 954-479-1150 or Enels002@fiu.edu
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Office of
Research
Integrity
Research
Compliance,
MARC 270

MEMORANDUM
To:

Michael McLean

CC:

Dr. Fatma Huffman
File

From:
Jada Dixon, MJ, MPH, IRB Coordinator
Date:

September 12, 2012

Proposal Title:

"Oxidative Stress Biomarkers in African
and Haitian Americans with and without
Type 2 Diabetes: The Relationship between
Serum Levels of Manganese Superoxide
Dismutase and mtDNA
8-hydroxy-2’-deoxyguanosine,
and Antioxidants"
IRB Exemption #

073112-01

The Health Sciences Institutional Review Board of
Florida International University has reviewed your
study for the use of human subjects via the Exempt
Review process. Your study was deemed Exempt by
the Institutional Review Board on July 31, 2012.
As a requirement of IRB approval you are required to:
1) Submit a completion report (Form B-2) upon
completion of your project in order for the file to
be closed.
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ID #: _____________________

Date _____________________

CVD RISK STUDY: HAITIAN & AFRICAN AMERICAN
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Section I - Demographics
Please answer each of the following questions by filling in the blanks with
the correct answers or by choosing the single best answer.
Note: For this survey, a Health Care Provider refers to a doctor, nurse
practitioner, or physician assistant.
Q1.

Age: ____________ years old

Q2.

Birth date: __ __ /__ __ /__ __
( Month / Day / Year )

Q3.

Sex:

1

Male

2

Female

Q4.

Height: _______________ centimeters

Q5.

Weight: _______________ kilograms

Q6.

Waist Circumference: _______________ centimeters

Q7.

What year were you first told you had diabetes? (Please enter the year) _____

Q8.

What is your marital status? (check one box)
1

Never married

2

Married

3

Separated/Divorced

4

Widowed
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Q9.

Which country were you born in? (check one box)
1

Haiti

2

United States of America

3

Other________________

Q.10 How long have you been in the United States of America? (check one box)

Q11.

1

Less than one year

2

One to three years

3

Four to six years

4

Seven to ten years

5

Eleven to fifteen years

6

More than fifteen years

How much schooling have you had? (Years of formal schooling completed)
(check one box)
1

8 grades or less

2

Some high school

3

High school graduate or GED

4

Some college or technical school

5

College graduate (bachelor’s degree)

6

Graduate degree
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Q12.

Which of the following best describes your current employment status?
(check one box)
1

Working full‐time, 35 hours or more a week

2

Working part‐time, less than 35 hours a week

3

Unemployed or laid off and looking for work

4

Unemployed and not looking for work

5

Homemaker

6

In school

7

Retired

8

Disabled, not able to work

9

Something else? (Please specify): _______________________

Q13. How would you describe the insurance plan(s) you have had in the past 12
months?
(check all that apply)
1
2

An individual plan – the member pays for the plan premium
A group plan through an employer, union, etc. – the employer pays all or
part of the plan premium

3

U.S. Governmental Health Plan (e.g., Military, CHAMPUS, VA)

4

Medicaid

5

Medicare

6

I have not had an insurance plan in the past 12 months
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Q14. Which of the categories best describes your total annual combined household
income from all sources? (check one box)
1

Less than $5,000

2

$5,000 to $9,999

3

$10,000 to $19,999

4

$20,000 to $29,999

5

$30,000 to $39,999

6

$40,000 to $49,999

7

$50,000 to $59,999

8

$60,000 to $69,999

9

$60,000 to $69,999

10

$70,000 and over

11

Don’t know

Q15. How many person(s) age 18 years and over live in the same house you
live?_______

Q16. What language do you prefer to write something? (check one box)
1

Only Creole

2

More Creole than English

3

Both equally
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4

More English than Creole

5

Only English

Q17. What language do you prefer to speak with someone? (check one box)
1

Only Creole

2

More Creole than English

3

Both equally

4

More English than Creole

5

Only English

Q18. What language do you prefer to read with something? (check one box)
1

Only Creole

2

More Creole than English

3

Both equally

4

More English than Creole

5

Only English

Q19. Your smoking habit. (check one box)

1

Never smoked cigarettes, cigars or a pipe

2

I quit smoking cigarettes/cigars/pipes at least one year ago

3

I smoke cigarettes: ________ cigarettes per day

4

I smoke cigar: _________ cigars per day
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5

I smoke pipe: _________ pipes per day

6

I chew tobacco: __________ times per day

Q20. In general, would you say your health is: (check one box)

1

Excellent

2

3

Very Good

Good

4

5

Fair

Poor

Section II – Medication History

Q21. Are you currently (in last 6 months) prescribed any medicine for the treatment of
diabetes by your physician? (check one box)

1

2

No

Yes

If “yes” check all the medication(s) that apply:
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ORAL DIABETES MEDICATION(S):

1

No

2

Yes

◨ If “yes” How many oral diabetes medication(s) you take?
_________


INSULIN:

1

No

2

Yes

Q22. Are you currently (in last 6 months) prescribed any other medicine prescribed by
your physician? (check one box)

1

2

No

Yes

If “yes” check all the medication(s) that apply:

Cholesterol:

1

No

2

Yes

Hypertension:

1

No

2

Yes

Diuretics:

1

No

2

Yes

Depression:

1

No

2

Yes

Aspirin:

1

No

2

Yes

Pain Relievers:

1

No

2

Yes

Estrogen Replacement Therapy:

1

No

2

Yes

Other(s):____________________________________________________________
_____
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Q23. Are you currently (in last 6 months) taking any other non‐prescription medication
(over‐the‐counter)?

1

2

No

Yes

If “yes” check all the medication(s) that apply:

Antacids and Acid Reducers:

1

No

2

Yes

Antidiarrheals:

1

No

2

Yes

Antiemetic Medicines:

1

No

2

Yes

Antihistamines:

1

No

2

Yes

Cough Medicines:

1

No

2

Yes

Decongestants:

1

No

2

Yes

Laxatives:

1

No

2

Yes

Pain Relievers:

1

No

2

Yes
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If “yes” check all the medication(s) that apply:

Aspirin (Bayer, St. Joseph)
1 No
2 Yes

Ketoprofen (Orudis KT)
1 No
2 Yes

1

1

No

No

Yes

Ibuprofen (Advil, Motrin)

Yes

Naproxen (Aleve)

2

2

Other(s):____________________________________________________________
_____

Section III – Family History

Q24. Family history of diabetes (check all that apply)

1

Your mother has diabetes

2

Your father has diabetes

3

Your son has diabetes

4

Your daughter has diabetes

5

You have no family history of diabetes

6

You don’t know your family history of diabetes

Q25. Family history of premature coronary heart disease (check all that apply)
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1

Your mother had coronary heart disease before age 65 years old

2

Your sister had coronary heart disease before age 65 years old

3

Your father had coronary heart disease before age 55 years old

4

Your brother had coronary heart disease before age 55 years old

5

You have no family history of coronary heart disease

6

You don’t know your family history of coronary heart disease

153

Section IV – Support

Q1. I want a lot of help and support from my family or friends in:
(circle one answer for each line)

Does
Strongly
Disag

Somewhat
Disagree

Somewhat Strongly
Neutral

Not

Agree

Agree

Apply

ree
following my meal
plan.

1

2

3

4

5

N/A

taking my
medicine.

1

2

3

4

5

N/A

taking care of my
feet.

1

2

3

4

5

N/A

getting enough
physical activity.

1

2

3

4

5

N/A

testing my sugar.

1

2

3

4

5

N/A

handling my
feelings about
diabetes.

1

2

3

4

5

N/A
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Q2. My family or friends help and support me a lot to:
(circle one answer for each line)

Does
Strongly Somewhat

Somewhat Strongly

Not

Disagree

Disagree

Neutral

Agree

Agree

a) follow my meal
plan.

1

2

3

4

5

N/A

b) take my medicine.

1

2

3

4

5

N/A

c) take care of my
feet.

1

2

3

4

5

N/A

d) get enough
physical activity.

1

2

3

4

5

N/A

e) test my sugar.

1

2

3

4

5

N/A

f) handle my feelings
about diabetes.

1

2

3

4

5

N/A
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Apply

Q3. My family or friends: (circle one answer for each line)

Somewhat Strongly

Strongly

Somewhat

Disagree

Disagree

Neutral

a) accept me and my
diabetes.

1

2

3

4

5

b) feel uncomfortable about
me because of my
diabetes.

1

2

3

4

5

c) encourage or reassure me
about my diabetes.

1

2

3

4

5

d) discourage or upset me
about my diabetes.

1

2

3

4

5

e) listen to me when I want
to talk about my diabetes.

1

2

3

4

5

f) nag me about diabetes.

1

2

3

4

5

Ag

Q4. Who helps you the most in caring for your diabetes? (check only one box)

1

Spouse

2

Other family members

3

Friends

4

Paid helper
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Agree

5

Doctor

6

Nurse

7

Case manager

8

Other health care professional

9

No one
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Section V ‐ Diet Adherence Scale

Q1.

Has any health care provider or nurse

1

No

2

Yes

3

Not sure

told you to follow a meal plan or diet?
Never
Q2. How often do you follow a meal plan
or diet?
Q3.

1

Sometimes
2

3

Have you been told to follow a schedule for

Always
4

5

1

No

2

Yes

1

No

2

Yes

1

No

2

Yes

your meals and snacks?

Q4.

Have you been told to weigh or measure
your food?

Q5.

Have you been told to use exchange lists or
food group lists to plan your meals?
Never

Sometimes

Always

Q6.

How often do you follow the schedule
for your meals and snacks?

1

2

3

4

5

Q7.

How often do you weigh or measure
your food?

1

2

3

4

5

Q8.

How often do you (or the person who
cooks your food) use the exchange
lists or food group lists to plan your
meals?

1

2

3

4

5

Section VI ‐ Exercise Barriers Scale
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For the following questions, please circle the appropriate response.
(circle one answer for each line)

Q1.

How often do you have trouble getting
enough exercise because:

Rarely

Sometimes

Often

a) it takes too much effort?

1

2

3

4

5

b) you don't believe it is useful?

1

2

3

4

5

c) you don't like to do it?

1

2

3

4

5

d) you have a health problem?

1

2

3

4

5

e) it makes your diabetes more
difficult to control?

1

2

3

4

5

Section VII – Education / Advice Received

Q1.
Has your health care provider or nurse ever told you to take special care of your
feet?
(check one box)

1

No

2

Yes

3

Not Sure

Q2.
Has your health care provider or nurse ever told you to follow an exercise
program?
(check one box)

1

No

2

Yes

3

Not Sure
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Q3. Has your health care provider or nurse ever told you to follow a meal
plan or diet?
(check one box)

1

No

2

Yes

3

Not Sure

Q4.
Have you ever received diabetes education? (for example: attended a series of
classes or
series of meetings with a diabetes educator) (check one box)

1

No

2

Yes

3

Not Sure
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Section VIII ‐ Long‐Term Care Benefits Scale

For the following questions, please circle the appropriate response.
(circle one answer for each line)

Q1. Taking the best possible care
of diabetes will delay or
prevent:

Strongly
Strongly
Disagree Disagree Neutral Agree Agree

a) eye problems

1

2

3

4

5

b) kidney problems

1

2

3

4

5

c) foot problems

1

2

3

4

5

d) hardening of the arteries

1

2

3

4

5

e) heart disease

1

2

3

4

5
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Section IX ‐ Understanding
Q1. How do you rate your understanding
of: (circle one answer for each
line)

Poor

Good

Excellent

a) overall diabetes care

1

2

3

4

5

b) coping with stress

1

2

3

4

5

c) diet for blood sugar control

1

2

3

4

5

d) the role of exercise in diabetes

1

2

3

4

5

e) medications you are taking

1

2

3

4

5

f) how to use the results of blood
sugar monitoring

1

2

3

4

5

g) how diet, exercise, and
medicines affect blood sugar
levels

1

2

3

4

5

h) prevention and treatment of high
blood sugar

1

2

3

4

5

i) prevention and treatment of low
blood sugar

1

2

3

4

5

j) prevention of long-term
complications of diabetes

1

2

3

4

5

k) foot care

1

2

3

4

5

l) benefits of improving blood
sugar control

1

2

3

4

5

m) pregnancy and diabetes

1

2

3

4

5
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Section X ‐ Self‐Care Adherence:

For the following questions, please circle the appropriate response.
(circle one answer for each line)

Sometimes

Never

Always

Q1. I keep my blood sugar in good
control.

1

2

3

4

5

Q2. I keep my glycated hemoglobin
(HbA1C) in good control.

1

2

3

4

5

Q3. I keep my weight under control.

1

2

3

4

5

Q4. I do the things I need to do for my
diabetes (diet, medicine, exercise).

1

2

3

4

5
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ID # _____________________

CVD RISK STUDY:
HAITIAN & AFRICAN AMERICAN
Weight: ____________lb

Weight: ____________kg

Height: ____________ in

Height: ____________cm

BMI: ____________

Waist circumference: ____________in

Waist circumference: ____________cm

Blood Pressure: 1

Systolic: ______________mm Hg

Diastolic: _____________ mm Hg

Blood Pressure: 2

Systolic: ______________mm Hg

Diastolic: _____________ mm Hg

Average Blood Pressures

Average Systolic: ______________mm Hg

Average Diastolic _____________ mm Hg
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Aim
1. To determine
differences in
Serum MnSOD
and 8OHdG by
diabetes status and
ethnicity.

Hypotheses

Variables

1a: Serum levels of
MnSOD will be lower
in participants with
T2D as compared with
those without T2D,
independent of
ethnicity.
1b: Serum levels of
8OHdG will be higher
in participants with
T2D when compared to
those without T2D,
independent of
ethnicity.
1c: There will be an
inverse relationship
between serum levels
of MnSOD and
8OHdG in participants
with T2D, independent
of ethnicity.
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Dependent Variables

Test
1a: ANCOVA

1a: MnSOD
1b: 8OHdG

1b: ANCOVA

Independent Variables

1c: Pearson’s
correlation and
multiple linear
regression

Diabetes status,
ethnicity
Covariates
Age, gender, smoking,
education, BMI,
energy intakes

2. To examine the
relationships of
serum MnSOD
and 8OHdG with
various dietary
antioxidants by
diabetes status and
ethnicity.

2a: Serum 8OHdG
levels will be
negatively associated
with dietary intake of
antioxidants,
independent of
diabetes status and
ethnicity.
2b: MnSOD levels
will be negatively
associated with dietary
intake of antioxidants,
independent of
diabetes status and
ethnicity

3. To examine the
relationships of
glycemic control
(A1C and FPG)
with various
dietary
antioxidants in
T2D by ethnicity.

3a: There will be no
relationship between
serum A1C and dietary
antioxidants in
participants with T2D
independent of
ethnicity.
3b: There will be no
relationship between
fasting plasma glucose
level and any of the
dietary antioxidant
intakes in T2D
independent of
ethnicity.
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Dependent Variables
2a: 8OHdG
2b: MnSOD
Independent Variables
Dietary intake of
antioxidants (Vit E,
Vit C, Vit D,
carotenoids)

2a: Pearson’s
correlation and
multiple linear
regression.
2b: Pearson’s
correlation and
multiple linear
regression.

Diabetes status,
ethnicity
Covariates
Age, gender, smoking,
education, BMI,
energy Intakes
Dependent Variables
3a: A1C
3b: FPG
Independent Variables
Dietary intake of
antioxidants (Vit E,
Vit C, Vit D,
carotenoids)
ethnicity
Covariates
Age, gender, smoking,
education, BMI,
energy intakes

3a: Pearson’s
correlation and
multiple linear
regression
3b: Pearson’s
correlation and
multiple linear
regression
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